BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 1994;272:65-69. [PMID: 8007082 DOI: 10.1001/jama.272.1.65] [Cited by in Crossref: 498] [Cited by in F6Publishing: 366] [Article Influence: 17.8] [Reference Citation Analysis]
Number Citing Articles
1 Jiang Z, Qian X, Wang Z, Dong Y, Pan Y, Zhang Z, Wang S. Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021. Front Cell Infect Microbiol 2022;12:970630. [DOI: 10.3389/fcimb.2022.970630] [Reference Citation Analysis]
2 Mazumder S, Rahman F, Akter F, Khatun R, Akter S, Saha S, Jilani MS, Sayeed M, Haq J. Asymptomatic Helicobacter pylori infection among rural children and adolescents in Bangladesh. IMC Journal of Medical Science. [DOI: 10.55010/imcjms.16.017] [Reference Citation Analysis]
3 Cho J, Prashar A, Jones NL, Moss SF. Helicobacter pylori Infection. Gastroenterol Clin North Am 2021;50:261-82. [PMID: 34024441 DOI: 10.1016/j.gtc.2021.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 Boylan KE, Patrey S, McMullen PD, Tesic V, Weber CR, Hart J, Setia N. Objective Visual Analog Scale for Biopsy Diagnosis of Helicobacter pylori Infection in Clinical Practice. Am J Surg Pathol 2021;45:672-9. [PMID: 33534221 DOI: 10.1097/PAS.0000000000001681] [Reference Citation Analysis]
5 Lin Y, Zheng Y, Wang HL, Wu J. Global Patterns and Trends in Gastric Cancer Incidence Rates (1988-2012) and Predictions to 2030. Gastroenterology 2021;161:116-127.e8. [PMID: 33744306 DOI: 10.1053/j.gastro.2021.03.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
6 Robles-Medranda C, Valero M, Puga-Tejada M, Oleas R, Baquerizo-Burgos J, Soria-Alcívar M, Alvarado-Escobar H, Pitanga-Lukashok H. High-definition optical magnification with digital chromoendoscopy detects gastric mucosal changes in dyspeptic-patients. World J Gastrointest Endosc 2020; 12(1): 23-32 [PMID: 31942231 DOI: 10.4253/wjge.v12.i1.23] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Eshun JK, Black DD, Casteel HB, Horn H, Beavers-may T, Jetton CA, Parham DM. Comparison of Immunohistochemistry and Silver Stain for the Diagnosis of Pediatric Helicobacter pylori Infection in Urease-negative Gastric Biopsies. Pediatr Dev Pathol 2001;4:82-8. [DOI: 10.1007/s100240010129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
8 Sisman P, Pekgoz M, Bayrakci I, Sisman M, Cander S, Oz Gul O, Erturk E, Ersoy C. Evaluation of upper gastrointestinal system in acromegaly. Ann Endocrinol (Paris). 2019;80:196-201. [PMID: 31227172 DOI: 10.1016/j.ando.2019.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Rasane RK, Horn CB, Coleoglou Centeno AA, Fiore NB, Torres Barboza M, Zhang Q, Bochicchio KM, Punch LJ, Bochicchio GV, Ilahi ON. Are Patients with Perforated Peptic Ulcers Who are Negative for Helicobacter pylori at a Greater Risk? Surg Infect (Larchmt). 2019;20:444-448. [PMID: 30939075 DOI: 10.1089/sur.2018.249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
10 Kavitt RT, Lipowska AM, Anyane-yeboa A, Gralnek IM. Diagnosis and Treatment of Peptic Ulcer Disease. The American Journal of Medicine 2019;132:447-56. [DOI: 10.1016/j.amjmed.2018.12.009] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 19.0] [Reference Citation Analysis]
11 Mahachai V, Vilaichone RK, Pittayanon R, Rojborwonwitaya J, Leelakusolvong S, Maneerattanaporn M, Chotivitayatarakorn P, Treeprasertsuk S, Kositchaiwat C, Pisespongsa P, Mairiang P, Rani A, Leow A, Mya SM, Lee YC, Vannarath S, Rasachak B, Chakravuth O, Aung MM, Ang TL, Sollano JD, Trong Quach D, Sansak I, Wiwattanachang O, Harnsomburana P, Syam AF, Yamaoka Y, Fock KM, Goh KL, Sugano K, Graham D. Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018;33:37-56. [PMID: 28762251 DOI: 10.1111/jgh.13911] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 12.8] [Reference Citation Analysis]
12 Yuan XY, Wang Y, Wang MY. The type IV secretion system in Helicobacter pylori. Future Microbiol 2018;13:1041-54. [PMID: 29927340 DOI: 10.2217/fmb-2018-0038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
13 Fabrizi F, Martin P. Helicobacter Pylori Infection in Patients with End-Stage Renal Disease. Int J Artif Organs 2000;23:157-64. [DOI: 10.1177/039139880002300303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
14 Liu WZ, Xie Y, Lu H, Cheng H, Zeng ZR, Zhou LY, Chen Y, Wang JB, Du YQ, Lu NH; Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori and Peptic Ulcer. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter. 2018;23:e12475. [PMID: 29512258 DOI: 10.1111/hel.12475] [Cited by in Crossref: 102] [Cited by in F6Publishing: 154] [Article Influence: 25.5] [Reference Citation Analysis]
15 Cano-Contreras AD, Rascón O, Amieva-Balmori M, Ríos-Gálvez S, Maza YJ, Meixueiro-Daza A, Roesch-Dietlen F, Remes-Troche JM. Approach, attitudes, and knowledge of general practitioners in relation to Helicobacter pylori is inadequate. There is much room for improvement! Rev Gastroenterol Mex (Engl Ed) 2018;83:16-24. [PMID: 28385468 DOI: 10.1016/j.rgmx.2017.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
16 Kobo-Greenhut A, Megnezi R, Reuveni H, Ben Shlomo I. Improving Quality Management in Medicine: Is It "Catch 22" All Over Again? Am J Med Qual 2017;32:572. [PMID: 28402683 DOI: 10.1177/1062860617700266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Ji X, Zhao H, Zhang Y, Chen X, Li J, Li B. Construction of Novel Plasmid Vectors for Gene Knockout in Helicobacter pylori. Curr Microbiol 2016;73:897-903. [DOI: 10.1007/s00284-016-1140-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Fairman KA, Motheral BR. Helicobacter Pylori Eradication in Clinical Practice: Retreatment Rates and Costs of Competing Regimens. Ann Pharmacother 2000;34:721-8. [DOI: 10.1345/aph.19271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Merga YJ, O'Hara A, Burkitt MD, Duckworth CA, Probert CS, Campbell BJ, Pritchard DM. Importance of the alternative NF-κB activation pathway in inflammation-associated gastrointestinal carcinogenesis. Am J Physiol Gastrointest Liver Physiol 2016;310:G1081-90. [PMID: 27102559 DOI: 10.1152/ajpgi.00026.2016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
20 Lesjak M, Simin N, Orcic D, Franciskovic M, Knezevic P, Beara I, Aleksic V, Svircev E, Buzas K, Mimica-dukic N. Binary and Tertiary Mixtures of Satureja hortensis and Origanum vulgare Essential Oils as Potent Antimicrobial Agents Against Helicobacter pylori: Essential Oil Mixture Against H . pylori. Phytother Res 2016;30:476-84. [DOI: 10.1002/ptr.5552] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
21 Lin Z, Cheng S, Yan Q, Liu X, Zheng W, Hu X, Li J, Zhang J, Xiang T, Zheng J, Zhang J. Development of an immunochromatographic lateral flow device for rapid detection of Helicobacter pylori stool antigen. Clin Biochem 2015;48:1298-303. [PMID: 26256542 DOI: 10.1016/j.clinbiochem.2015.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
22 Tan J, Wang Y, Sun X, Cui W, Ge J, Lin L. The effect of Helicobacter pylori eradication therapy on the development of gastroesophageal reflux disease. Am J Med Sci. 2015;349:364-371. [PMID: 25767896 DOI: 10.1097/maj.0000000000000429] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
23 Lundell L. The physiological background behind and course of development of the first proton pump inhibitor. Scandinavian Journal of Gastroenterology 2015;50:680-4. [DOI: 10.3109/00365521.2015.1013981] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
24 Saf C, Gulcan EM, Ozkan F, Cobanoglu Saf SP, Vitrinel A. Assessment of p21, p53 expression, and Ki-67 proliferative activities in the gastric mucosa of children with Helicobacter pylori gastritis. European Journal of Gastroenterology & Hepatology 2015;27:155-61. [DOI: 10.1097/meg.0000000000000246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
25 Zhou L, Zhao F, Hu B, Fang Y, Miao Y, Huang Y, Ji D, Zhang J, Xu L, Zhang Y, Bao Z, Zhao H. A Creative Helicobacter pylori Diagnosis Scheme Based on Multiple Genetic Analysis System: Qualification and Quantitation. Helicobacter 2015;20:343-52. [DOI: 10.1111/hel.12206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
26 Otero LL, Ruiz VE, Perez Perez GI. Helicobacter pylori: The balance between a role as colonizer and pathogen. Best Practice & Research Clinical Gastroenterology 2014;28:1017-29. [DOI: 10.1016/j.bpg.2014.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
27 Pilotto A, Franceschi M. Helicobacter pylori infection in older people. World J Gastroenterol 2014; 20(21): 6364-6373 [PMID: 24914358 DOI: 10.3748/wjg.v20.i21.6364] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
28 Wu JY, Wang SSW, Lee YC, Yamaoka Y, Graham DY, Jan CM, Wang WM, Wu DC. Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. World J Gastroenterol 2014; 20(12): 3343-3349 [PMID: 24695835 DOI: 10.3748/wjg.v20.i12.3343] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
29 Yuan Y, Ford AC, Khan KJ, Gisbert JP, Forman D, Leontiadis GI, Tse F, Calvet X, Fallone C, Fischbach L. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013;CD008337. [PMID: 24338763 DOI: 10.1002/14651858.cd008337.pub2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 66] [Article Influence: 3.1] [Reference Citation Analysis]
30 Carvalho MA, Machado NC, Ortolan EV, Rodrigues MA. Upper gastrointestinal histopathological findings in children and adolescents with nonulcer dyspepsia with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2012;55:523-529. [PMID: 22684348 DOI: 10.1097/mpg.0b013e3182618136] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
31 Tahara T, Arisawa T. Potential usefulness of DNA methylation as a risk marker for digestive cancer associated with inflammation. Expert Rev Mol Diagn 2012;12:489-97. [PMID: 22702365 DOI: 10.1586/erm.12.38] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
32 Li HB, Zhang JY, He YF, Chen L, Li B, Liu KY, Yang WC, Zhao Z, Zou QM, Wu C. Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice. Vaccine. 2012;31:120-126. [PMID: 23137845 DOI: 10.1016/j.vaccine.2012.10.091] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
33 Queiroz DM, Carneiro JG, Braga-Neto MB, Fialho AB, Fialho AM, Goncalves MH, Rocha GA, Rocha AM, Braga LL. Natural history of Helicobacter pylori infection in childhood: eight-year follow-up cohort study in an urban community in northeast of Brazil. Helicobacter. 2012;17:23-29. [PMID: 22221612 DOI: 10.1111/j.1523-5378.2011.00894.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
34 Huang YK, Wu MC, Wang SS, Kuo CH, Lee YC, Chang LL, Wang TH, Chen YH, Wang WM, Wu DC. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. J Dig Dis. 2012;13:232-238. [PMID: 22435509 DOI: 10.1111/j.1751-2980.2012.00575.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
35 Gisbert JP, Calvet X, Cosme A, Almela P, Feu F, Bory F, Santolaria S, Aznárez R, Castro M, Fernández N. Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding. Am J Gastroenterol. 2012;107:1197-1204. [PMID: 22613904 DOI: 10.1038/ajg.2012.132] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
36 Arisawa T, Tahara T, Shiroeda H, Matsue Y, Minato T, Nomura T, Yamada H, Hayashi R, Saito T, Matsunaga K. Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3’-UTR, influence susceptibility to gastric cancer. Hum Immunol. 2012;73:747-752. [PMID: 22537748 DOI: 10.1016/j.humimm.2012.04.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
37 Wang AY, Peura DA. The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Gastrointest Endosc Clin N Am. 2011;21:613-635. [PMID: 21944414 DOI: 10.1016/j.giec.2011.07.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
38 Manguso F, Riccio E, de Nucci G, Aiezza ML, Amato G, Degl’Innocenti L, Piccirillo MM, De Dominicis G, Santoro T, Trimarco E, Balzano A. Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal antiinflammatory drug consumption. World J Gastroenterol 2011; 17(40): 4509-4516 [PMID: 22110282 DOI: 10.3748/wjg.v17.i40.4509] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
39 Choi J, Kim CH, Kim D, Chung SJ, Song JH, Kang JM, Yang JI, Park MJ, Kim YS, Yim JY. Prospective evaluation of a new stool antigen test for the detection of Helicobacter pylori, in comparison with histology, rapid urease test, (13)C-urea breath test, and serology. J Gastroenterol Hepatol. 2011;26:1053-1059. [PMID: 21362044 DOI: 10.1111/j.1440-1746.2011.06705.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
40 Çoban S, Soykan I, Toruner M, Akbulut H, Atli T, Ensari A. The effect of age and Helicobacter pylori infection on gastric epithelial cell kinetics. Clin Res Hepatol Gastroenterol 2011;35:661-5. [PMID: 21763231 DOI: 10.1016/j.clinre.2011.05.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Kawamura M, Abe S, Oikawa K, Terai S, Saito M, Shibuya D, Kato K, Shimada T, Uedo N, Masuda T. Topographic differences in gastric micromucosal patterns observed by magnifying endoscopy with narrow band imaging. J Gastroenterol Hepatol. 2011;26:477-483. [PMID: 21155881 DOI: 10.1111/j.1440-1746.2010.06527.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
42 Moon HI, Lee YC, Lee JH. Phenol glycosides with in vitro anti-Helicobacter pylori activity from Hypericum erectum Thunb. Phytother Res 2011;25:1389-91. [PMID: 21469237 DOI: 10.1002/ptr.3453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
43 Sánchez-delgado J, Gené E, Suárez D, García-iglesias P, Brullet E, Gallach M, Feu F, Gisbert JP, Calvet X. Has H. pylori Prevalence in Bleeding Peptic Ulcer Been Underestimated? A Meta-Regression. American Journal of Gastroenterology 2011;106:398-405. [DOI: 10.1038/ajg.2011.2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 5.2] [Reference Citation Analysis]
44 Fialho AM, Braga AB, Braga Neto MB, Carneiro JG, Rocha AM, Rodrigues MN, Queiroz DM, Braga LL. Younger siblings play a major role in Helicobacter pylori transmission among children from a low-income community in the Northeast of Brazil. Helicobacter. 2010;15:491-496. [PMID: 21073604 DOI: 10.1111/j.1523-5378.2010.00791.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
45 Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, Zhang G. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion. 2011;83:253-260. [PMID: 21282951 DOI: 10.1159/000280318] [Cited by in Crossref: 127] [Cited by in F6Publishing: 129] [Article Influence: 11.5] [Reference Citation Analysis]
46 Okubo M, Tahara T, Shibata T, Nakamura M, Kamiya Y, Yoshioka D, Maeda Y, Yonemura J, Ishizuka T, Arisawa T, Hirata I. Usefulness of magnifying narrow-band imaging endoscopy in the Helicobacter pylori-related chronic gastritis. Digestion. 2011;83:161-166. [PMID: 21266810 DOI: 10.1159/000321799] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
47 Janjetic MA, Goldman CG, Balcarce NE, Rua EC, González AB, Fuda JA, Meseri EI, Torti HE, Barrado J, Zubillaga MB, López LB, Boccio JR. Iron, zinc, and copper nutritional status in children infected with Helicobacter pylori. J Pediatr Gastroenterol Nutr 2010;51:85-9. [PMID: 20410842 DOI: 10.1097/MPG.0b013e3181c2c2cd] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
48 Song KH, Lee YC, Fan D, Ge Z, Ji F, Chen M, Jung HC, Bo J, Lee SW, Kim J. Healing Effects of Rebamipide and Omeprazole in Helicobacter pylori-Positive Gastric Ulcer Patients after Eradication Therapy: A Randomized Double-Blind, Multinational, Multi-Institutional Comparative Study. Digestion 2011;84:221-9. [DOI: 10.1159/000329353] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
49 Hwang TJ, Kim N, Kim HB, Lee BH, Nam RH, Park JH, Lee MK, Park YS, Lee DH, Jung HC. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol. 2010;44:536-543. [PMID: 20179610 DOI: 10.1097/mcg.0b013e3181d04592] [Cited by in Crossref: 30] [Cited by in F6Publishing: 54] [Article Influence: 2.5] [Reference Citation Analysis]
50 Lazaridou E, Giannopoulou C, Fotiadou C, Vakirlis E, Trigoni A, Ioannides D. The potential role of microorganisms in the development of rosacea. J Dtsch Dermatol Ges. 2011;9:21-25. [PMID: 21059171 DOI: 10.1111/j.1610-0387.2010.07513.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
51 Kim P, Jeong C. Anti-Gastritis and Anti-Oxidant Effects of Chenopodium album Linne Fractions and Betaine. Biomolecules and Therapeutics 2010;18:433-41. [DOI: 10.4062/biomolther.2010.18.4.433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
52 Unge P. Assessment and significance of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 1997;11:33-9. [DOI: 10.1111/j.1365-2036.1997.tb00791.x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
53 Miehlke S, Graham DY. Antimicrobial therapy of peptic ulcers. Int J Antimicrob Agents 1997;8:171-8. [PMID: 18611798 DOI: 10.1016/s0924-8579(97)00368-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
54 Wang YR, Richter JE, Dempsey DT. Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg. 2010;251:51-58. [PMID: 20009753 DOI: 10.1097/sla.0b013e3181b975b8] [Cited by in Crossref: 155] [Cited by in F6Publishing: 120] [Article Influence: 12.9] [Reference Citation Analysis]
55 Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Hirata I, Arisawa T. Effect of polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan. Mol Carcinog 2009;48:1030-7. [PMID: 19496079 DOI: 10.1002/mc.20554] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
56 Goh K, Cutler A, Chua A, Ding R, Kandasami P, Mazlam M, Raj S. Optimal treatment for duodenal ulcer disease: A cost–decision analysis in Malaysian patients. Journal of Gastroenterology and Hepatology 2002;14:32-8. [DOI: 10.1046/j.1440-1746.1999.01814.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
57 Habu Y, Inokuchi H, Kiyota K, Hayashi K, Watanabe Y, Kawai K, Stålhammar N. Economic evaluation of Helicobacter pylori eradication for the treatment of duodenal ulcer disease in Japan: A decision analysis to assess eradication strategy in comparison with a conventional strategy. Journal of Gastroenterology and Hepatology 2009;13:280-7. [DOI: 10.1111/j.1440-1746.1998.01556.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
58 Koizumi W, Tanabe S, Hibi K, Imaizumi H, Ohida M, Okabe H, Saigenji K, Okayasu I. A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori. Journal of Gastroenterology and Hepatology 2009;13:301-4. [DOI: 10.1111/j.1440-1746.1998.01559.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
59 Chow DK, Sung JJ. Non-NSAID non-H. pylori ulcer disease. Best Pract Res Clin Gastroenterol. 2009;23:3-9. [PMID: 19258182 DOI: 10.1016/j.bpg.2008.11.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
60 Tahara T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Arisawa T, Hirata I. Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis. Gastrointest Endosc. 2009;70:246-253. [PMID: 19386303 DOI: 10.1016/j.gie.2008.11.046] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 7.1] [Reference Citation Analysis]
61 Tahara T, Shibata T, Yamashita H, Hirata I, Arisawa T. Effect of cyclin D1 (CCND1) polymorphism on gastric premalignant condition. Clin Chem Lab Med 2008;46:1696-701. [PMID: 19055446 DOI: 10.1515/CCLM.2008.340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
62 Kuo CH, Hu HM, Kuo FC, Hsu PI, Chen A, Yu FJ, Tsai PY, Wu IC, Wang SW, Li CJ. Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. J Antimicrob Chemother. 2009;63:1017-1024. [PMID: 19246508 DOI: 10.1093/jac/dkp034] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 4.7] [Reference Citation Analysis]
63 Zhang YY, Xia HH, Zhuang ZH, Zhong J. Review article: 'true' re-infection of Helicobacter pylori after successful eradication--worldwide annual rates, risk factors and clinical implications. Aliment Pharmacol Ther 2009;29:145-60. [PMID: 18945250 DOI: 10.1111/j.1365-2036.2008.03873.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
64 Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Yamamoto K. Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation. J Gastroenterol Hepatol. 2009;24:107-113. [PMID: 18823429 DOI: 10.1111/j.1440-1746.2008.05606.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
65 Asfeldt AM, Straume B, Steigen SE, Løchen M, Florholmen J, Bernersen B, Johnsen R, Paulssen EJ. Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: The Sørreisa gastrointestinal disorder study. Eur J Epidemiol 2008;23:625-33. [DOI: 10.1007/s10654-008-9275-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
66 Gisbert JP, Calvet X. Review article: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther. 2009;30:791-815. [PMID: 19706147 DOI: 10.1111/j.1365-2036.2009.04105.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
67 Assimakopoulos SF, Thomopoulos KC, Louvros E, Theocharis G, Giannikoulis C, Katsakoulis E, Nikolopoulou VN. Changes in Indications for Upper Gastrointestinal Tract Endoscopy and Endoscopic Findings during the Last Fifteen Years in South-Western Greece. The American Journal of the Medical Sciences 2008;336:21-6. [DOI: 10.1097/maj.0b013e31815adeea] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
68 Gené E, Sánchez-delgado J, Calvet X, Azagra R. Manejo de la infección por Helicobacter pylori en atención primaria en España. Gastroenterología y Hepatología 2008;31:327-34. [DOI: 10.1157/13123599] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
69 Yamac D, Ayyildiz T, Coşkun U, Akyürek N, Dursun A, Seckin S, Koybasioglu F. Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma. Pathol Res Pract 2008;204:527-36. [PMID: 18462890 DOI: 10.1016/j.prp.2008.01.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
70 Chen S, Li Y, Yu C. Oligonucleotide microarray: a new rapid method for screening the 23S rRNA gene of Helicobacter pylori for single nucleotide polymorphisms associated with clarithromycin resistance. J Gastroenterol Hepatol. 2008;23:126-131. [PMID: 18171351 DOI: 10.1111/j.1440-1746.2007.04900.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
71 Wu IC, Wu DC, Hsu PI, Lu CY, Yu FJ, Wang TE, Chang WH, Chen JJ, Kuo FC, Wu JY. Rabeprazole- versus esomeprazole-based eradication regimens for H. pylori infection. Helicobacter. 2007;12:633-637. [PMID: 18001406 DOI: 10.1111/j.1523-5378.2007.00553.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
72 Stettin D, Waldmann A, Ströhle A, Hahn A. Association between Helicobacter pylori-infection, C-reactive protein and status of B vitamins. Adv Med Sci 2008;53:205-13. [PMID: 19230307 DOI: 10.2478/v10039-008-0050-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
73 Wang H, Shao SH. Detection and analysis of OipA, HopX and HopW of Helicobacter pylori. Shijie Huaren Xiaohua Zazhi 2007; 15(35): 3710-3714 [DOI: 10.11569/wcjd.v15.i35.3710] [Reference Citation Analysis]
74 Tseng GY, Lin HJ, Fang CT, Yang HB, Tseng GC, Wang PC, Hung TL, Deng YC, Cheng YT, Huang CH. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study. Aliment Pharmacol Ther. 2007;26:925-933. [PMID: 17767477 DOI: 10.1111/j.1365-2036.2007.03438.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
75 Gisbert JP, Calvet X, Feu F, Bory F, Cosme A, Almela P, Santolaria S, Aznárez R, Castro M, Fernández N. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding. Helicobacter. 2007;12:279-286. [PMID: 17669099 DOI: 10.1111/j.1523-5378.2007.00490.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
76 Mirzaei J, Siavoshi F, Emami S, Safari F, Khoshayand MR, Shafiee A, Foroumadi A. Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2-yl]thiomorpholines and related compounds. Eur J Med Chem. 2008;43:1575-1580. [PMID: 18192086 DOI: 10.1016/j.ejmech.2007.11.019] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
77 Malfertheiner P. Helicobacter pylori--a timeless source of lessons and research initiatives. Helicobacter 2007;12 Suppl 2:85-9. [PMID: 17991183 DOI: 10.1111/j.1523-5378.2007.00577.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
78 Messina GA, De Vito IE, Raba J. Screen-printed immunosensor for quantification of human serum IgG antibodies to Helicobacter pylori. Sensors and Actuators B: Chemical 2007;128:23-30. [DOI: 10.1016/j.snb.2007.05.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
79 Ogura K, Mitsuno Y, Maeda S, Hirata Y, Yanai A, Shibata W, Ohmae T, Yoshida H, Kawabe T, Omata M. Efficacy and Safety of Faropenem in Eradication Therapy of Helicobacter pylori: Faropenem against Helicobacter pylori. Helicobacter 2007;12:618-22. [DOI: 10.1111/j.1523-5378.2007.00551.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
80 Gisbert JP, Pajares R, Pajares JM. Evolution of Helicobacter pylori Therapy from a Meta-analytical Perspective. Helicobacter 2007;12:50-8. [DOI: 10.1111/j.1523-5378.2007.00576.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
81 Ndip RN, Malange Tarkang AE, Mbullah SM, Luma HN, Malongue A, Ndip LM, Nyongbela K, Wirmum C, Efange SM. In vitro anti-Helicobacter pylori activity of extracts of selected medicinal plants from North West Cameroon. J Ethnopharmacol. 2007;114:452-457. [PMID: 17913416 DOI: 10.1016/j.jep.2007.08.037] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
82 Tahara T, Arisawa T, Wang F, Shibata T, Nakamura M, Sakata M, Hirata I, Nakano H. Toll-like receptor 2 -196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci. 2007;98:1790-1794. [PMID: 17711514 DOI: 10.1111/j.1349-7006.2007.00590.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 96] [Article Influence: 6.5] [Reference Citation Analysis]
83 Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seo GS, Kim HU, Baik GH, Sin CS, Cho SH, Oh BH. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333-40. [DOI: 10.1111/j.1523-5378.2007.00504.x] [Cited by in Crossref: 200] [Cited by in F6Publishing: 192] [Article Influence: 13.3] [Reference Citation Analysis]
84 Savas JF, Miller TA. Gastric surgery. Curr Opin Gastroenterol 2002;18:678-81. [PMID: 17033347 DOI: 10.1097/00001574-200211000-00007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
85 Clyne M, Dolan B, Reeves EP. Bacterial factors that mediate colonization of the stomach and virulence of Helicobacter pylori. FEMS Microbiol Lett. 2007;268:135-143. [PMID: 17313591 DOI: 10.1111/j.1574-6968.2007.00648.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
86 Chimenti F, Bizzarri B, Bolasco A, Secci D, Chimenti P, Carradori S, Granese A, Rivanera D, Lilli D, Zicari A, Scaltrito MM, Sisto F. A novel class of selective anti-Helicobacter pylori agents 2-oxo-2H-chromene-3-carboxamide derivatives. Bioorganic & Medicinal Chemistry Letters 2007;17:3065-71. [DOI: 10.1016/j.bmcl.2007.03.050] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
87 Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007;21:205-14. [PMID: 17382273 DOI: 10.1016/j.bpg.2006.10.005] [Cited by in Crossref: 139] [Cited by in F6Publishing: 147] [Article Influence: 9.3] [Reference Citation Analysis]
88 Cheng D, Xu WR, Liu CX. Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials. World J Gastroenterol 2007; 13(17): 2496-2503 [PMID: 17552035 DOI: 10.3748/wjg.v13.i17.2496] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
89 Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter. 2007;12:89-102. [PMID: 17309745 DOI: 10.1111/j.1523-5378.2007.00478.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
90 Wu DC, Wu IC, Wang SW, Lu CY, Ke HL, Yuan SS, Wang YY, Chang WH, Wang TE, Bair MJ. Comparison of stool enzyme immunoassay and immunochromatographic method for detecting Helicobacter pylori antigens before and after eradication. Diagn Microbiol Infect Dis. 2006;56:373-378. [PMID: 17157673 DOI: 10.1016/j.diagmicrobio.2006.07.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
91 D'Elios MM, Montecucco C, de Bernard M. VacA and HP-NAP, Ying and Yang of Helicobacter pylori-associated gastric inflammation. Clin Chim Acta. 2007;381:32-38. [PMID: 17368441 DOI: 10.1016/j.cca.2007.02.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
92 Masaoka T, Suzuki H, Kurabayashi K, Nomoto Y, Nishizawa T, Mori M, Hibi T. Could frameshift mutations in the frxA and rdxA genes of Helicobacter pylori be a marker for metronidazole resistance?: FRXA AND RDXA GENES TO METRONIDAZOLE RESISTANCE IN H. PYLORI. Alimentary Pharmacology & Therapeutics 2006;24:81-7. [DOI: 10.1111/j.1365-2036.2006.00029.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
93 Bizri AR, Nuwayhid IA, Hamadeh GN, Steitieh SW, Choukair AM, Musharrafieh UM. Association between hepatitis A virus and Helicobacter pylori in a developing country: the saga continues. J Gastroenterol Hepatol 2006;21:1615-21. [PMID: 16928226 DOI: 10.1111/j.1440-1746.2006.04268.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
94 Collins J, Ali-ibrahim A, Smoot DT. Antibiotic Therapy for Helicobacter pylori. Medical Clinics of North America 2006;90:1125-40. [DOI: 10.1016/j.mcna.2006.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
95 Marzio L, Coraggio D, Capodicasa S, Grossi L, Cappello G. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole. Helicobacter. 2006;11:237-242. [PMID: 16882326 DOI: 10.1111/j.1523-5378.2006.00407.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 2.8] [Reference Citation Analysis]
96 Moesinger RC, Bender J, Duncan M, Magnuson T, Harmon JW. Surgical intervention and understanding of diseases of the stomach and duodenum. Curr Opin Gastroenterol 1999;15:509-15. [PMID: 17023998 DOI: 10.1097/00001574-199911000-00009] [Reference Citation Analysis]
97 Schubert ML. Stomach and duodenum. Curr Opin Gastroenterol 1999;15:455-6. [PMID: 17023990 DOI: 10.1097/00001574-199911000-00001] [Reference Citation Analysis]
98 Terry K, Go AC, Ottemann KM. Proteomic mapping of a suppressor of non-chemotactic cheW mutants reveals that Helicobacter pylori contains a new chemotaxis protein. Mol Microbiol. 2006;61:871-882. [PMID: 16879644 DOI: 10.1111/j.1365-2958.2006.05283.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
99 Lee JU, Kim O. Natural maternal transmission of H pylori in Mongolian gerbils. World J Gastroenterol 2006; 12(35): 5663-5667 [PMID: 17007019 DOI: 10.3748/wjg.v12.i35.5663] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
100 Kountouras J, Gavalas E, Zavos C, Stergiopoulos C, Chatzopoulos D, Kapetanakis N, Gisakis D. Alzheimer's disease and Helicobacter pylori infection: Defective immune regulation and apoptosis as proposed common links. Med Hypotheses. 2007;68:378-388. [PMID: 16979298 DOI: 10.1016/j.mehy.2006.06.052] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
101 Goldman CG, Barrado DA, Balcarce N, Rua EC, Oshiro M, Calcagno ML, Janjetic M, Fuda J, Weill R, Salgueiro MJ. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition. 2006;22:984-988. [PMID: 16978844 DOI: 10.1016/j.nut.2006.06.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
102 Hashemi MR, Rahnavardi M, Bikdeli B, Zahedani MD. H pylori infection among 1000 southern Iranian dyspeptic patients. World J Gastroenterol 2006; 12(34): 5479-5482 [PMID: 17006984 DOI: 10.3748/wjg.v12.i34.5479] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
103 Goldman C, Barrado A, Janjetic M, Balcarce N, Rua EC, Oshiro M, Calcagno ML, Sarrasague MM, Fuda J, Weill R, Zubillaga M, Perez-Perez GI, Boccio J. Factors associated with H pylori epidemiology in symptomatic children in Buenos Aires, Argentina. World J Gastroenterol 2006; 12(33): 5384-5388 [PMID: 16981273 DOI: 10.3748/wjg.v12.i33.5384] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
104 Masaoka T, Suzuki H, Kurabayashi K, Nomoto Y, Nishizawa T, Mori M, Hibi T. Could frameshift mutations in the frxA and rdxA genes of Helicobacter pylori be a marker for metronidazole resistance? Aliment Pharmacol Ther Symp Series 2006;2:81-7. [DOI: 10.1111/j.1746-6342.2006.00029.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
105 Kim JM, Kim JS, Kim N, Kim SG, Jung HC, Song IS. Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. Int J Antimicrob Agents. 2006;28:6-13. [PMID: 16750904 DOI: 10.1016/j.ijantimicag.2006.02.015] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
106 Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Kodama M, Fujioka T. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial. J Gastroenterol Hepatol 2006;21:1048-53. [DOI: 10.1111/j.1440-1746.2005.04038.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
107 Kato S, Ritsuno H, Ohnuma K, Iinuma K, Sugiyama T, Asaka M. Safety and Efficacy of One‐Week Triple Therapy for Eradicating Helicobacter pylori in Children. Helicobacter 2001;3:278-82. [DOI: 10.1046/j.1523-5378.1998.08030.x-i1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
108 Yamazaki T, Inoue M, Yamada K, Taneike I, Yamamoto T, Sasaki N. Persistent colonization and genetic diversity of Helicobacter pylori among patients with severe neurological impairment. J Hosp Infect 2006;63:350-2. [PMID: 16713020 DOI: 10.1016/j.jhin.2006.02.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
109 Pache M, Flammer J. A Sick Eye in a Sick Body? Systemic Findings in Patients with Primary Open-angle Glaucoma. Survey of Ophthalmology 2006;51:179-212. [DOI: 10.1016/j.survophthal.2006.02.008] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 5.8] [Reference Citation Analysis]
110 Tsai JY, Chen BT, Cheng HC, Chen HY, Hsaio NW, Lyu PC, Sun YJ. Crystal structure of HP0242, a hypothetical protein from Helicobacter pylori with a novel fold. Proteins 2006;62:1138-43. [PMID: 16395670 DOI: 10.1002/prot.20864] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
111 Moges F, Kassu A, Mengistu G, Adugna S, Andualem B, Nishikawa T, Ota F. Seroprevalence of Helicobacter pylori in dyspeptic patients and its relationship with HIV infection, ABO blood groups and life style in a university hospital, Northwest Ethiopia. World J Gastroenterol 2006; 12(12): 1957-1961 [PMID: 16610007 DOI: 10.3748/wjg.v12.i12.1957] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
112 Chimenti F, Bizzarri B, Bolasco A, Secci D, Chimenti P, Carradori S, Granese A, Rivanera D, Lilli D, Scaltrito MM, Brenciaglia MI. Synthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. Eur J Med Chem 2006;41:208-12. [PMID: 16377035 DOI: 10.1016/j.ejmech.2005.11.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
113 Ito M, Tanaka S, Kamada T, Haruma K, Chayama K. Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis. World J Gastroenterol 2006; 12(1): 10-16 [PMID: 16440410 DOI: 10.3748/wjg.v12.i1.10] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
114 Kim SG, Kim JS, Kim JM, Chae Jung H, Sung Song I. Inhibition of proinflammatory cytokine expression by NF-kappaB (p65) antisense oligonucleotide in Helicobacter pylori-infected mice. Helicobacter 2005;10:559-66. [PMID: 16302981 DOI: 10.1111/j.1523-5378.2005.00365.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
115 Genuis SJ. Diagnosis: contemporary medical hubris; Rx: a tincture of humility. J Eval Clin Pract 2006;12:24-30. [DOI: 10.1111/j.1365-2753.2005.00599.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
116 Zúñiga-noriega JR, Bosques-padilla FJ, Pérez-pérez GI, Tijerina-menchaca R, Flores-gutiérrez JP, Maldonado Garza HJ, Garza-gonzález E. Diagnostic Utility of Invasive Tests and Serology for the Diagnosis of Helicobacter pylori Infection in Different Clinical Presentations. Archives of Medical Research 2006;37:123-8. [DOI: 10.1016/j.arcmed.2005.04.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
117 Shimatani T, Inoue M, Iwamoto K, Hyogo H, Yokozaki M, Saeki T, Tazuma S, Horikawa Y. Prevalence of Helicobacter pylori infection, endoscopic gastric findings and dyspeptic symptoms among a young Japanese population born in the 1970s. J Gastroenterol Hepatol 2005;20:1352-7. [PMID: 16105120 DOI: 10.1111/j.1440-1746.2005.03866.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
118 Ippoliti G, Rinaldi M, Pellegrini C, Viganò M. Incidence of cancer after immunosuppressive treatment for heart transplantation. Crit Rev Oncol Hematol. 2005;56:101-113. [PMID: 15979322 DOI: 10.1016/j.critrevonc.2005.03.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
119 Wong KK, Chung PH, Lan LC, Lin SC, Tam PK. Trends in the prevalence of Helicobacter pylori in symptomatic children in the era of eradication. Journal of Pediatric Surgery 2005;40:1844-7. [DOI: 10.1016/j.jpedsurg.2005.08.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
120 Koch A, Krause TG, Krogfelt K, Olsen OR, Fischer TK, Melbye M. Seroprevalence and Risk Factors for Helicobacter pylori Infection in Greenlanders. Helicobacter 2005;10:433-42. [DOI: 10.1111/j.1523-5378.2005.00351.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
121 Ott EA, Mazzoleni LE, Edelweiss MI, Sander GB, Wortmann AC, Theil AL, Somm G, Cartell A, Rivero LF, Uchôa DM, Francesconi CF, Prolla JC. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. Aliment Pharmacol Ther 2005;21:1231-9. [PMID: 15882244 DOI: 10.1111/j.1365-2036.2005.02461.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
122 Goodman KJ, O’rourke K, Day RS, Wang C, Nurgalieva Z, Phillips CV, Aragaki C, Campos A, de la Rosa JM. Dynamics of Helicobacter pylori infection in a US-Mexico cohort during the first two years of life. Int J Epidemiol. 2005;34:1348-1355. [PMID: 16076858 DOI: 10.1093/ije/dyi152] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
123 Hung LC, Ching JY, Sung JJ, To KF, Hui AJ, Wong VW, Leong RW, Chan HL, Wu JC, Leung WK. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology. 2005;128:1845-1850. [PMID: 15940620 DOI: 10.1053/j.gastro.2005.03.026] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
124 Booka M, Okuda M, Shin K, Miyashiro E, Hayashi H, Yamauchi K, Tamura Y, Yoshikawa N. Polymerase chain reaction--restriction fragment length polymorphism analysis of clarithromycin-resistant Helicobacter pylori infection in children using stool sample. Helicobacter. 2005;10:205-213. [PMID: 15904478 DOI: 10.1111/j.1523-5378.2005.00312.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
125 Yakoob J, Jafri W, Jafri N, Islam M, Abid S, Hamid S, AliShah H, Shaikh H. Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan. World J Gastroenterol 2005; 11(23): 3562-3565 [PMID: 15962375 DOI: 10.3748/wjg.v11.i23.3562] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
126 Lui SL, Wong WM, Ng SY, Chan TM, Lai KN, Lo WK. Seroprevalence of Helicobacter pylori in Chinese patients on continuous ambulatory peritoneal dialysis. Nephrology (Carlton) 2005;10:21-4. [PMID: 15705177 DOI: 10.1111/j.1440-1797.2005.00367.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
127 Kikkawa A, Iwakiri R, Ootani H, Ootani A, Fujise T, Sakata Y, Amemori S, Tsunada S, Sakata H, Koyama T, Fujimoto K. Prevention of the rehaemorrhage of bleeding peptic ulcers: effects of Helicobacter pylori eradication and acid suppression. Aliment Pharmacol Ther 2005;21:79-84. [DOI: 10.1111/j.1365-2036.2005.02479.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
128 Kuepper-Nybelen J, Thefeld W, Rothenbacher D, Brenner H. Patterns of alcohol consumption and Helicobacter pylori infection: results of a population-based study from Germany among 6545 adults. Aliment Pharmacol Ther 2005;21:57-64. [PMID: 15644046 DOI: 10.1111/j.1365-2036.2004.02276.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
129 Albanidou-Farmaki E, Giannoulis L, Markopoulos A, Fotiades S, Aggouridaki X, Farmakis K, Papanayotou P. Outcome following treatment for Helicobacter pylori in patients with recurrent aphthous stomatitis. Oral Dis. 2005;11:22-26. [PMID: 15641963 DOI: 10.1111/j.1601-0825.2004.01053.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
130 Wang HH, Chou JW, Liao KF, Lin ZY, Lai HC, Hsu CH, Chen CB. One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy. World J Gastroenterol 2005; 11(11): 1680-1684 [PMID: 15786549 DOI: 10.3748/wjg.v11.i11.1680] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
131 Lim JW, Kim H, Kim JM, Kim JS, Jung HC, Kim KH. Cellular stress-related protein expression in Helicobacter pylori-infected gastric epithelial AGS cells. Int J Biochem Cell Biol. 2004;36:1624-1634. [PMID: 15147740 DOI: 10.1016/j.biocel.2004.01.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
132 Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327-341; quiz 342-344. [PMID: 15337973 DOI: 10.1016/j.jaad.2004.03.030] [Cited by in Crossref: 305] [Cited by in F6Publishing: 257] [Article Influence: 17.9] [Reference Citation Analysis]
133 Magistà AM, Ierardi E, Castellaneta S, Miniello VL, Lionetti E, Francavilla A, Ros P, Rigillo N, Di Leo A, Francavilla R. Helicobacter pylori Status and Symptom Assessment Two Years after Eradication in Pediatric Patients from a High Prevalence Area. Journal of Pediatric Gastroenterology & Nutrition 2005;40:312-8. [DOI: 10.1097/01.mpg.0000154662.39488.77] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
134 Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients. World J Gastroenterol 2005; 11(7): 976-981 [PMID: 15742399 DOI: 10.3748/wjg.v11.i7.976] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
135 Shi T, Liu W, Gao F, Shi G, Xiao S. Intranasal CpG-Oligodeoxynucleotide is a Potent Adjuvant of Vaccine against Helicobacter pylori, and T Helper 1 Type Response and Interferon-gamma Correlate with the Protection. Helicobacter 2005;10:71-9. [DOI: 10.1111/j.1523-5378.2005.00293.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
136 Chimenti F, Bizzarri B, Manna F, Bolasco A, Secci D, Chimenti P, Granese A, Rivanera D, Lilli D, Scaltrito M, Brenciaglia M. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives. Bioorganic & Medicinal Chemistry Letters 2005;15:603-7. [DOI: 10.1016/j.bmcl.2004.11.042] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
137 Kalach N, Mention K, Guimber D, Michaud L, Spyckerelle C, Gottrand F. Helicobacter pylori infection is not associated with specific symptoms in nonulcer-dyspeptic children. Pediatrics 2005;115:17-21. [PMID: 15629976 DOI: 10.1542/peds.2004-0131] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
138 Azuma T, Kato S, Zhou W, Yamazaki S, Yamakawa A, Ohtani M, Fujiwara S, Minoura T, Iinuma K, Kato T. Diversity of vacA and cagA genes of Helicobacter pylori in Japanese children. Aliment Pharmacol Ther. 2004;20 Suppl 1:7-12. [PMID: 15298599 DOI: 10.1111/j.1365-2036.2004.01980.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
139 Moran AP, Shiberu B, Ferris JA, Knirel YA, Senchenkova SN, Perepelov AV, Jansson P, Goldberg JB. Role of Helicobacter pylori rfaJ genes (HP0159 and HP1416) in lipopolysaccharide synthesis. FEMS Microbiology Letters 2004;241:57-65. [DOI: 10.1016/j.femsle.2004.10.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
140 Lee SY, Kim JJ, Lee JH, Kim YH, Rhee PL, Paik SW, Rhee JC. Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointest Endosc. 2004;60:213-217. [PMID: 15278047 DOI: 10.1016/s0016-5107(04)01683-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
141 Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, Kato M, Murakami K, Kato C, Shiotani A. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter. 2004;9:9-16. [PMID: 15156899 DOI: 10.1111/j.1083-4389.2004.00194.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
142 Harewood GC, Holub JL, Lieberman DA. Biopsy specimen acquisition in patients with newly diagnosed peptic ulcer disease as determined from a national endoscopic database. Gastrointest Endosc 2004;59:664-9. [PMID: 15114310 DOI: 10.1016/s0016-5107(04)00179-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
143 Chisholm SA, Watson CL, Teare EL, Saverymuttu S, Owen RJ. Non-invasive diagnosis of Helicobacter pylori infection in adult dyspeptic patients by stool antigen detection: does the rapid immunochromatography test provide a reliable alternative to conventional ELISA kits. J Med Microbiol. 2004;53:623-627. [PMID: 15184532 DOI: 10.1099/jmm.0.05502-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
144 de Bernard M, Cappon A, Del Giudice G, Rappuoli R, Montecucco C. The multiple cellular activities of the VacA cytotoxin of Helicobacter pylori. Int J Med Microbiol. 2004;293:589-597. [PMID: 15149036 DOI: 10.1078/1438-4221-00299] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
145 Watanabe H, Yamaguchi N, Kuwayama H, Sekine C, Uemura N, Kaise M, Nakamura T, Kubo M, Yoshida S, Haruma K. Improvement in gastric histology following Helicobacter pylori eradication therapy in Japanese peptic ulcer patients. J Int Med Res. 2003;31:362-369. [PMID: 14587302 DOI: 10.1177/147323000303100502] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
146 Ishiki K, Mizuno M, Take S, Nagahara Y, Yoshida T, Yamamoto K, Okada H, Yokota K, Oguma K, Shiratori Y. Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. Clinical Gastroenterology and Hepatology 2004;2:474-9. [DOI: 10.1016/s1542-3565(04)00165-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
147 Ohkusa T, Miwa H, Endo S, Okayasu I, Sato N. Helicobacter pylori is a fragile bacteria when stored at low and ultra-low temperatures. J Gastroenterol Hepatol. 2004;19:200-204. [PMID: 14731131 DOI: 10.1111/j.1440-1746.2004.03266.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
148 Yoshida Y, Matsuda K, Sasaki H, Matsumoto Y, Matsumoto S, Tawara S, Takasugi H. Studies on anti-Helicobacter pylori agents. Part 3: A novel, efficacious cephem derivative, FR193879. Bioorganic & Medicinal Chemistry Letters 2004;14:2627-31. [DOI: 10.1016/j.bmcl.2004.02.068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
149 Chisholm SA, Owen RJ. Frameshift mutations in frxA occur frequently and do not provide a reliable marker for metronidazole resistance in UK isolates of Helicobacter pylori. J Med Microbiol. 2004;53:135-140. [PMID: 14729935 DOI: 10.1099/jmm.0.05342-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
150 Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-muñoz E. Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer: META-ANALYSIS: H. PYLORI AND RECURRENT ULCER BLEEDING. Alimentary Pharmacology & Therapeutics 2004;19:617-29. [DOI: 10.1111/j.1365-2036.2004.01898.x] [Cited by in Crossref: 109] [Cited by in F6Publishing: 88] [Article Influence: 6.1] [Reference Citation Analysis]
151 Hiyama T, Tanaka S, Masuda H, Shima H, Kose K, Tuncel H, Ito M, Kitadai Y, Sumii M, Uemura N. Prevalence of Helicobacter pylori resistance to clarithromycin and metronidazole determined by 23S ribosomal RNA and rdxA gene analyses in Hiroshima, Japan. J Gastroenterol Hepatol. 2003;18:1202-1207. [PMID: 12974909 DOI: 10.1046/j.1440-1746.2003.03140.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
152 Singh M, Prasad KN, Yachha SK, Krishnani N. Genotypes of Helicobacter pylori in children with upper abdominal pain. J Gastroenterol Hepatol. 2003;18:1018-1023. [PMID: 12911656 DOI: 10.1046/j.1440-1746.2003.03119.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
153 Cruchet S, Obregon MC, Salazar G, Diaz E, Gotteland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition. 2003;19:716-721. [PMID: 12921879 DOI: 10.1016/s0899-9007(03)00109-6] [Cited by in Crossref: 113] [Cited by in F6Publishing: 101] [Article Influence: 6.3] [Reference Citation Analysis]
154 Lee SK, Lee YC, Chung JB, Chon CY, Moon YM, Kang JK, Park IS, Suh CO, Yang WI. Low grade gastric MALTOMA: Treatment strategies based on 10 year follow-up. World J Gastroenterol 2004; 10(2): 223-226 [PMID: 14716827 DOI: 10.3748/wjg.v10.i2.223] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
155 Ma F, Misumi J, Zhao W, Aoki K, Kudo M. Long-term treatment with sterigmatocystin, a fungus toxin, enhancesthe development of intestinal metaplasia of gastric mucosa in Helicobacter pylori- infected Mongolian gerbils. Scand J Gastroenterol. 2003;38:360-369. [PMID: 12739707 DOI: 10.1080/0036552031001699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
156 García-oria M, Hidalgo F, Gómez F, Quintanilla E, Codina-cazador A, Masvidal R, Mar García-gil MD. Reparación laparoscópica de las úlceras pépticas perforadas. Experiencia en la provincia de Girona durante el año 2002. Cirugía Española 2004;76:122. [DOI: 10.1016/s0009-739x(04)72374-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
157 Rocha GA, Rocha AM, Silva LD, Santos A, Bocewicz AC, Queiroz Rd Rde M, Bethony J, Gazzinelli A, Correa-Oliveira R, Queiroz DM. Transmission of Helicobacter pylori infection in families of preschool-aged children from Minas Gerais, Brazil. Trop Med Int Health. 2003;8:987-991. [PMID: 14629764 DOI: 10.1046/j.1360-2276.2003.01121.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 1.8] [Reference Citation Analysis]
158 Montecucco C, de Bernard M. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect. 2003;5:715-721. [PMID: 12814772 DOI: 10.1016/s1286-4579(03)00124-2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 4.1] [Reference Citation Analysis]
159 Xiao SD, Shi T. Is cranberry juice effective in the treatment and prevention of Helicobacter pylori infection of mice?: Cranberry juice for H. pylori infection in mice. Chinese Journal of Digestive Diseases 2003;4:136-9. [DOI: 10.1046/j.1443-9573.2003.00127.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
160 Ndip RN, MacKay WG, Farthing MJ, Weaver LT. Culturing Helicobacter pylori from clinical specimens: review of microbiologic methods. J Pediatr Gastroenterol Nutr. 2003;36:616-622. [PMID: 12717085 DOI: 10.1097/00005176-200305000-00005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
161 Russo A, Maconi G, Lombardo C, Settesoldi D, Ferrari D, Ravagnani F, Andreola S, Pizzetti P, Spinelli P, Bertario L. Human Leukocyte Antigen Class II Genes and Helicobacter pylori Infection: Does Genotype Overwhelm Environmental Exposure? Nutrition 2003;19:708-15. [DOI: 10.1016/s0899-9007(02)01034-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
162 Sykora J, Hejda V, Varvarovská J, Stozicky F, Gottrand F, Siala K. Helicobacter heilmannii related gastric ulcer in childhood. J Pediatr Gastroenterol Nutr. 2003;36:410-413. [PMID: 12604985 DOI: 10.1097/00005176-200303000-00022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
163 Weyermann M, Brenner H, Adler G, Yasar Z, Handke-vesely A, Grab D, Kreienberg R, Rothenbacher D. Helicobacter pylori infection and the occurrence and severity of gastrointestinal symptoms during pregnancy. American Journal of Obstetrics and Gynecology 2003;189:526-31. [DOI: 10.1067/s0002-9378(03)00486-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
164 Wheeldon T, Hoang TTH, Phung DC, Björkman A, Granström M, Sörberg M. Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment: EXPERIMENTAL TREATMENT OF H. PYLORI AND PEPTIC ULCER. Alimentary Pharmacology & Therapeutics 2003;18:93-100. [DOI: 10.1046/j.1365-2036.2003.01649.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
165 Gené E, Calvet X, Azagra R, Gisbert JP. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther. 2003;17:1137-1143. [PMID: 12752350 DOI: 10.1046/j.1365-2036.2003.01566.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 89] [Article Influence: 4.8] [Reference Citation Analysis]
166 Chang HY, Sharma VK, Howden CW, Gold BD. Knowledge, attitudes, and practice styles of North American pediatric gastroenterologists: Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2003;36:235-240. [PMID: 12548060 DOI: 10.1097/00005176-200302000-00015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
167 Xia HH, Lam SK, Wong WM, Hu WH, Lai KC, Wong SH, Leung SY, Yuen ST, Wright NA, Wong BC. Antralization at the edge of proximal gastric ulcers: does Helicobacter pylori infection play a role? World J Gastroenterol 2003;9:1265-9. [PMID: 12800237 DOI: 10.3748/wjg.v9.i6.1265] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
168 Okimoto T, Murakami K, Sato R, Miyajima H, Nasu M, Kagawa J, Kodama M, Fujioka T. Is the Recurrence of Helicobacter pylori Infection After Eradication Therapy Resultant from Recrudescence or Reinfection, in Japan. Helicobacter 2003;8:186-91. [DOI: 10.1046/j.1523-5378.2003.00143.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
169 Wong BC, Xia HH, Cheung HK, Ng FH, Wong SY, Chow KC, Lin SK, Yin Y, Wong WM, Yuen MF, Lam SK. Evaluation of two stool antigen tests for the detection of Helicobacter pylori infection in the Chinese population. J Gastroenterol Hepatol 2003;18:26-31. [PMID: 12519220 DOI: 10.1046/j.1440-1746.2003.02926.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
170 Umeda M, Kobayashi H, Takeuchi Y, Hayashi J, Morotome-Hayashi Y, Yano K, Aoki A, Ohkusa T, Ishikawa I. High prevalence of Helicobacter pylori detected by PCR in the oral cavities of periodontitis patients. J Periodontol. 2003;74:129-134. [PMID: 12593608 DOI: 10.1902/jop.2003.74.1.129] [Cited by in Crossref: 54] [Cited by in F6Publishing: 63] [Article Influence: 2.8] [Reference Citation Analysis]
171 Aull MJ, Buell JF, Peddi VR, Trofe J, Beebe TM, Hanaway MJ, Roy-Chaudhury P, Alloway RR, First MR, Woodle ES. MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature. Transplantation. 2003;75:225-228. [PMID: 12548128 DOI: 10.1097/01.tp.0000040875.50963.2c] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
172 Rothenbacher D, Winkler M, Gonser T, Adler G, Brenner H. Role of infected parents in transmission of helicobacter pylori to their children. Pediatr Infect Dis J. 2002;21:674-679. [PMID: 12237602 DOI: 10.1097/00006454-200207000-00014] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 3.7] [Reference Citation Analysis]
173 Lindsetmo R, Johnsen R, Revhaug A. Abdominal and dyspeptic symptoms in patients with peptic ulcer treated medically or surgically. British Journal of Surgery 1998;85:845-9. [DOI: 10.1046/j.1365-2168.1998.00711.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
174 Taneike I, Goshi S, Tamura Y, Wakisaka-Saito N, Matsumori N, Yanase A, Shimizu T, Yamashiro Y, Toyoda S, Yamamoto T. Emergence of clarithromycin-resistant Helicobacter pylori (CRHP) with a high prevalence in children compared with their parents. Helicobacter. 2002;7:297-305. [PMID: 12390209 DOI: 10.1046/j.1523-5378.2002.00100.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
175 Bazzoli F, Bianchi Porro G, Bianchi MG, Molteni M, Pazzato P, Zagari RM. Treatment of Helicobacter pylori infection. Indications and regimens: an update. Dig Liver Dis. 2002;34:70-83. [PMID: 11926576 DOI: 10.1016/s1590-8658(02)80062-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
176 Ko JS, Seo JK. cag pathogenicity island of Helicobacter pylori in Korean children. Helicobacter. 2002;7:232-236. [PMID: 12165030 DOI: 10.1046/j.1523-5378.2002.00094.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
177 Chan FK, Leung WK. Peptic-ulcer disease. Lancet. 2002;360:933-941. [PMID: 12354485 DOI: 10.1016/s0140-6736(02)11030-0] [Cited by in Crossref: 151] [Cited by in F6Publishing: 130] [Article Influence: 7.6] [Reference Citation Analysis]
178 Glynn MK, Friedman CR, Gold BD, Khanna B, Hutwagner L, Iihoshi N, Revollo C, Quick R. Seroincidence of Helicobacter pylori infection in a cohort of rural Bolivian children: acquisition and analysis of possible risk factors. Clin Infect Dis. 2002;35:1059-1065. [PMID: 12384839 DOI: 10.1086/342910] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
179 Grove DI, Koutsouridis G. Increasing resistance of Helicobacter pylori to clarithromycin: is the horse bolting? Pathology. 2002;34:71-73. [PMID: 11902451 DOI: 10.1080/00313020120105624] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
180 Seo M, Okada M, Shirotani T, Nishimura H, Maeda K, Aoyagi K, Sakisaka S. Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan. J Clin Gastroenterol 2002;34:129-34. [PMID: 11782605 DOI: 10.1097/00004836-200202000-00005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
181 Uc A, Chong SK. Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in children. J Pediatr Gastroenterol Nutr. 2002;34:281-285. [PMID: 11964952 DOI: 10.1097/00005176-200203000-00010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
182 Grignon B, Tankovic J, Mégraud F, Glupczynski Y, Husson MO, Conroy MC, Emond JP, Loulergue J, Raymond J, Fauchère JL. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. Microb Drug Resist. 2002;8:61-66. [PMID: 12002651 DOI: 10.1089/10766290252913773] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
183 Ashour AA, Magalhã£es PP, Mendes EN, Collares GB, Gusmã£o VR, Queiroz DM, Nogueira AMM, Rocha GA, Oliveira CA. Distribution of vacA genotypes in Helicobacter pylori strains isolated from Brazilian adult patients with gastritis, duodenal ulcer or gastric carcinoma. FEMS Immunology & Medical Microbiology 2002;33:173-8. [DOI: 10.1111/j.1574-695x.2002.tb00588.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 2.7] [Reference Citation Analysis]
184 van Leerdam ME, Tytgat GN. Review article: Helicobacter pylori infection in peptic ulcer haemorrhage. Aliment Pharmacol Ther. 2002;16 Suppl 1:66-78. [PMID: 11849131 DOI: 10.1046/j.1365-2036.2002.0160s1066.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
185 O'Connor HJ. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits. Aliment Pharmacol Ther 2002;16:487-96. [PMID: 11876702 DOI: 10.1046/j.1365-2036.2002.01183.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
186 Singh V, Trikha B, Nain CK, Singh K, Vaiphei K. Epidemiology of Helicobacter pylori and peptic ulcer in India. Journal of Gastroenterology and Hepatology 2002;17:659-65. [DOI: 10.1046/j.1440-1746.2002.02746.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
187 Rothenbacher D, Bode G, Brenner H. History of breastfeeding and Helicobacter pylori infection in pre-school children: results of a population-based study from Germany. International Journal of Epidemiology 2002;31:632-7. [DOI: 10.1093/ije/31.3.632] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
188 Dzierzanowska-Fangrat K, Rozynek E, Józwiak P, Celińska-Cedro D, Madaliński K, Dzierzanowska D. Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland. Int J Antimicrob Agents 2001;18:387-90. [PMID: 11691574 DOI: 10.1016/s0924-8579(01)00421-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
189 Bhang CS, Lee HS, Kim SS, Song HJ, Sung YJ, Kim JI, Chung IS, Sun HS, Park DH, Lee YS. Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter. 2002;7:14-21. [PMID: 11886470 DOI: 10.1046/j.1523-5378.2002.00051.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
190 Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol. 2002;31:128-139. [PMID: 11914309 DOI: 10.1093/ije/31.1.128] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 3.8] [Reference Citation Analysis]
191 Nie Y, Li Y, Wu H, Sha W, Du H, Dai S, Wang H, Li Q. Colloidal Bismuth Pectin: An Alternative to Bismuth Subcitrate for the Treatment of Helicobacter pylori – Positive Duodenal Ulcer. Helicobacter 2002;4:128-34. [DOI: 10.1046/j.1523-5378.1999.98281.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
192 Sharma VK, Sahai AV, Corder FA, Howden CW. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Ther. 2001;15:1939-1947. [PMID: 11736725 DOI: 10.1046/j.1365-2036.2001.01134.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
193 Rupnow MF, Shachter RD, Owens DK, Parsonnet J. Quantifying the population impact of a prophylactic Helicobacter pylori vaccine. Vaccine 2001;20:879-85. [PMID: 11738753 DOI: 10.1016/s0264-410x(01)00401-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
194 Yu WK, Chow PKH, Y Tan S, Ng EH, Goh ASW, Soo KC, Aw SE. FIVE MICRO‐CURIE UREA BREATH TEST FOR THE DIAGNOSIS OF HELICOBACTER PYLORI INFECTION: EVALUATION IN A SOUTH‐EAST ASIAN POPULATION. Aust N Z J Surg 2002;69:37-40. [DOI: 10.1046/j.1440-1622.1999.01489.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
195 Choi IJ, Jung HC, Choi KW, Kim JH, Ahn DS, Yang US, Rew JS, Lee SI, Rhee JC, Chung IS, Chung JM, Hong WS. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002;16:145-51. [PMID: 11856089 DOI: 10.1046/j.1365-2036.2002.01130.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
196 Tulassay Z, Kryszewski A, Dite P, Kleczkowski D, Rudzinski J, Bartuzi Z, Hasselgren G, Larkö A, Wrangstadh M. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 2001;13:1457-65. [PMID: 11742194 DOI: 10.1097/00042737-200112000-00009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
197 Baena JM, López C, Hidalgo A, Rams F, Jiménez S, García M, Hernández MR. Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week: . European Journal of Gastroenterology & Hepatology 2002;14:291-6. [DOI: 10.1097/00042737-200203000-00014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
198 Naka Y, Aihara T, Keto Y, Okabe S. Effects of dexamethasone and FK506 on Helicobacter pylori-induced gastritis and bacterial viability in Mongolian gerbils. J Physiol Paris 2001;95:443-51. [PMID: 11595473 DOI: 10.1016/s0928-4257(01)00061-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
199 Sarkio S, Rautelin H, Kyllönen L, Honkanen E, Salmela K, Halme L. Should Helicobacter pylori infection be treated before kidney transplantation? Nephrol Dial Transplant 2001;16:2053-7. [PMID: 11572896 DOI: 10.1093/ndt/16.10.2053] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
200 Ecclissato C, Carvalho AF, Ferraz JG, de Nucci G, De Souza CA, Pedrazzoli J Jr. Prevalence of peptic lesions in asymptomatic, healthy volunteers. Dig Liver Dis 2001;33:403-6. [PMID: 11529651 DOI: 10.1016/s1590-8658(01)80011-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
201 Miwa H, Sato N. Functional dyspepsia and Helicobacter pylori infection: A recent consensus up to 1999. Journal of Gastroenterology and Hepatology 2002;15:60-5. [DOI: 10.1046/j.1440-1746.2000.02177.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
202 Gold BD, Robie‐suh K, Sherman PM. Pediatric Issues Workshop Summary. Helicobacter 2001;3:305-9. [DOI: 10.1046/j.1523-5378.1998.08047.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
203 Graham, Hoffman, Anderson, Qureshi, Osato, El-zimaity. Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection: RANITIDINE BISMUTH CITRATE TRIPLE THERAPY. Alimentary Pharmacology & Therapeutics 1999;13:169-72. [DOI: 10.1046/j.1365-2036.1999.00465.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
204 Kovacs, Campbell, Richter, Haber, Jennings, Rose. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H 2 -receptor antagonists: MAINTENANCE PPI THERAPY IN H 2 RA RESISTANT DUODENAL ULCER. Alimentary Pharmacology & Therapeutics 1999;13:959-67. [DOI: 10.1046/j.1365-2036.1999.00569.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
205 Elitsur Y, Lawrence Z. Non-Helicobacter pylori related duodenal ulcer disease in children. Helicobacter. 2001;6:239-243. [PMID: 11683927 DOI: 10.1046/j.1523-5378.2001.00034.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
206 McNulty CA, Wilson MP, Havinga W, Johnston B, O'Gara EA, Maslin DJ. A pilot study to determine the effectiveness of garlic oil capsules in the treatment of dyspeptic patients with Helicobacter pylori. Helicobacter. 2001;6:249-253. [PMID: 11683929 DOI: 10.1046/j.1523-5378.2001.00036.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
207 Asaka M, Sugiyama T, Kato M, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter. 2001;6:254-261. [PMID: 11683930 DOI: 10.1046/j.1523-5378.2001.00037.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 5.2] [Reference Citation Analysis]
208 Asaka M, Satoh K, Sugano K, Sugiyama T, Takahashi S, Fukuda Y, Ota H, Murakami K, Kimura K, Shimoyama T. Guidelines in the management of Helicobacter pylori infection in Japan. Helicobacter. 2001;6:177-186. [PMID: 11683920 DOI: 10.1046/j.1523-5378.2001.00027.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 2.9] [Reference Citation Analysis]
209 Gold BD. Helicobacter pylori infection in children. Curr Probl Pediatr Adolesc Health Care. 2001;31:247-266. [PMID: 11595896 DOI: 10.1067/mps.2001.118485] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
210 Dojo M, Azuma T, Saito T, Ohtani M, Muramatsu A, Kuriyama M. Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan. Digestive and Liver Disease 2001;33:671-5. [DOI: 10.1016/s1590-8658(01)80043-8] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
211 Lee TH, Yang JC, Lee SC, Farn SS, Wang TH. Effect of mouth washing on the. J Gastroenterol Hepatol. 2001;16:261-263. [PMID: 11339415 DOI: 10.1046/j.1440-1746.2001.02437.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
212 Shiotani A, Nishioka S, Iguchi M, Yanaoka K, Okada K, Tamai H, Mantani Y, Itoh H, Graham DY. Duodenal erosions after eradication of Helicobacter pylori infection. Gastrointestinal Endoscopy 2001;54:448-53. [DOI: 10.1067/mge.2001.118134] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
213 Mizushima T, Sugiyama T, Komatsu Y, Ishizuka J, Kato M, Asaka M. Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J Clin Microbiol. 2001;39:2463-2465. [PMID: 11427555 DOI: 10.1128/jcm.39.7.2463-2465.2001] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 3.8] [Reference Citation Analysis]
214 Meyer JM, Silliman NP, Dixon CA, Siepman NY, Sugg JE, Hopkins RJ. Helicobacter pylori and early duodenal ulcer status post-treatment: a review. Helicobacter. 2001;6:84-92. [PMID: 11422462 DOI: 10.1046/j.1523-5378.2001.00013.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
215 Rabeneck L, Cook KF, Wristers K, Souchek J, Menke T, Wray NP. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol. 2001;54:755-765. [PMID: 11470383 DOI: 10.1016/s0895-4356(00)00365-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 2.0] [Reference Citation Analysis]
216 Calvet X, Gené E, López T, Gisbert JP. What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis. Aliment Pharmacol Ther 2001;15:1067-76. [PMID: 11421884 DOI: 10.1046/j.1365-2036.2001.01031.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
217 Berg G, Bode G, Blettner M, Boeing H, Brenner H. Helicobacter pylori infection and serum ferritin: A population-based study among 1806 adults in Germany. Am J Gastroenterol. 2001;96:1014-1018. [PMID: 11316140 DOI: 10.1111/j.1572-0241.2001.03686.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
218 Rabeneck L, Menke T. Increased numbers of women, older individuals, and Blacks receive health care for dyspepsia in the United States. J Clin Gastroenterol 2001;32:307-9. [PMID: 11276272 DOI: 10.1097/00004836-200104000-00005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
219 Poms RE, Tatini SR. Survival of Helicobacter pylori in ready-to-eat foods at 4 degrees C. Int J Food Microbiol. 2001;63:281-286. [PMID: 11246912 DOI: 10.1016/s0168-1605(00)00441-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 1.8] [Reference Citation Analysis]
220 Yeomans ND, Garas G, Hawkey CJ. The nonsteroidal anti-inflammatory drugs controversy. Gastroenterol Clin North Am. 2000;29:791-805. [PMID: 11190064 DOI: 10.1016/S0889-8553(05)70147-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
221 Sontag SJ, O'connell S, Schnell T, Chejfec G, Seidel J, Sonnenberg A. Reduced Symptoms and Need for Antisecretory Therapy in Veterans 3 Years After Helicobacter pylori Eradication With Ranitidine Bismuth Citrate/Amoxicillin/Clarithromycin. American Journal of Gastroenterology 2001;96:1390-5. [DOI: 10.1111/j.1572-0241.2001.03771.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
222 Kiss J, Lamarque D, Moran AP, Pozsár J, Morschl É, László F, Whittle BJ. Helicobacter pylori lipopolysaccharide-provoked injury to rat gastroduodenal microvasculature involves inducible nitric oxide synthase. European Journal of Pharmacology 2001;420:175-9. [DOI: 10.1016/s0014-2999(01)01008-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
223 Brenner H, Bode G, Adler G, Hoffmeister A, Koenig W, Rothenbacher D. Alcohol as a gastric disinfectant The complex relationship between alcohol consumption and current Helicobacter pylori infection. Epidemiology. 2001;12:209-214. [PMID: 11246582 DOI: 10.1097/00001648-200103000-00013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
224 Yoshida Y, Matsuda K, Sasaki H, Matsumoto Y, Matsumoto S, Tawara S, Takasugi H. Studies on anti-Helicobacter pylori agents. Part 2: new cephem derivatives. Bioorg Med Chem 2000;8:2317-35. [PMID: 11026544 DOI: 10.1016/s0968-0896(00)00163-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
225 Kountouras J, Mylopoulos N, Boura P, Bessas C, Chatzopoulos D, Venizelos J, Zavos C. Relationship between Helicobacter pylori infection and glaucoma. Ophthalmology. 2001;108:599-604. [PMID: 11237916 DOI: 10.1016/s0161-6420(00)00598-4] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 3.2] [Reference Citation Analysis]
226 Goodman KJ, Cockburn M. The Role of Epidemiology in Understanding the Health Effects of Helicobacter pylori: . Epidemiology 2001;12:266-71. [DOI: 10.1097/00001648-200103000-00023] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
227 Dundon WG, Bernard MD, Montecucco C. Virulence factors of Helicobacter pylori. International Journal of Medical Microbiology 2001;290:647-58. [DOI: 10.1016/s1438-4221(01)80002-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
228 Veldhuyzen Van Zanten S, Lauritsen K, Delchier JC, Labenz J, De Argila CM, Lind T, Treichel HC, Stubberöd A, Cockeram A, Hasselgren G, Göthe L, Wrangstadh M, Sinclair P. One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. Aliment Pharmacol Ther 2000;14:1605-11. [PMID: 11121908 DOI: 10.1046/j.1365-2036.2000.00911.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
229 Vincze Á, Karádi O, Hunyady B, Pakodi F, Sutő G, Mózsik G. One year follow-up of patients after successful helicobacter pylori eradication therapy. Journal of Physiology-Paris 2001;95:457-60. [DOI: 10.1016/s0928-4257(01)00063-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
230 Lai KC, Hui WM, Wong BC, Hu WH, Lam SK. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage. Aliment Pharmacol Ther. 2000;14:1071-1076. [PMID: 10930902 DOI: 10.1046/j.1365-2036.2000.00803.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
231 Coelho LGV, León-barúa R, Quigley EM. Latin-American Consensus Conference on Helicobacter Pylori Infection. American Journal of Gastroenterology 2000;95:2688-91. [DOI: 10.1111/j.1572-0241.2000.03174.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 2.5] [Reference Citation Analysis]
232 Forman D, Bazzoli F, Bennett C, Broutet N, Chiba N, Deeks JJ, Fallone C, Fischbach L, Hunt R, Lahaie R, Laheij R, Megraud F, Moayyedi P, Oderda G, Palli D, Savarino V, Misiewicz G(, Unge P, Gisbert JP, Kuipers EJ, Calvet X, Harris A, Huang JQ, Forman D. Therapies for the eradication of Helicobacter pylori. The Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd002298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
233 Wolfe MM, Sachs G. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology. 2000;118:S9-31. [PMID: 10868896 DOI: 10.1016/s0016-5085(00)70004-7] [Cited by in Crossref: 216] [Cited by in F6Publishing: 170] [Article Influence: 9.8] [Reference Citation Analysis]
234 Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, Yamaji Y, Akanuma M, Shiratori Y, Omata M. H. pylori activates NF-κB through a signaling pathway involving IκB kinases, NF-κB—inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology 2000;119:97-108. [DOI: 10.1053/gast.2000.8540] [Cited by in Crossref: 139] [Cited by in F6Publishing: 135] [Article Influence: 6.3] [Reference Citation Analysis]
235 Suzuki H, Ishii H. Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury. J Gastroenterol Hepatol. 2000;15 Suppl:D46-D54. [PMID: 10759220 DOI: 10.1046/j.1440-1746.2000.02147.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
236 Cappell MS, Schein JR. Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity. Gastroenterol Clin North Am. 2000;29:97-124, vi. [PMID: 10752019 DOI: 10.1016/s0889-8553(05)70109-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
237 Farrell JJ, Friedman LS. Gastrointestinal bleeding in older people. Gastroenterol Clin North Am 2000;29:1-36, v. [PMID: 10752016 DOI: 10.1016/s0889-8553(05)70106-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
238 Yoshida H, Hirota K, Ogura K, Maeda S, Shiratori Y, Sasaki Y, Omata M. Determination of the optimal cut-off value for the [13C]-urea breath test based on a Helicobacter pylori-specific polymerase chain reaction assay. J Gastroenterol Hepatol. 2000;15:155-160. [PMID: 10735539 DOI: 10.1046/j.1440-1746.2000.02056.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
239 Watanabe S, Takagi A, Koga Y, Kamiya S, Miwa T. Helicobacter pylori induces apoptosis in gastric epithelial cells through inducible nitric oxide. J Gastroenterol Hepatol. 2000;15:168-174. [PMID: 10735541 DOI: 10.1046/j.1440-1746.2000.02062.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.2] [Reference Citation Analysis]
240 Alarcón T, Domingo D, Prieto N, López-Brea M. PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J Clin Microbiol 2000;38:923-5. [PMID: 10655418 DOI: 10.1128/JCM.38.2.923-925.2000] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
241 Soll AH, McCarthy D. NSAID-related gastrointestinal complications. Clin Cornerstone 1999;1:42-56. [PMID: 10682181 DOI: 10.1016/s1098-3597(99)90088-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
242 Stadtländer CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis. 1999;20:2195-2208. [PMID: 10590210 DOI: 10.1093/carcin/20.12.2195] [Cited by in Crossref: 126] [Cited by in F6Publishing: 122] [Article Influence: 5.7] [Reference Citation Analysis]
243 Wierzbicki WB, Hagmeyer KO. Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease. Pharmacotherapy 2000;20:52-63. [PMID: 10641975 DOI: 10.1592/phco.20.1.52.34659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
244 Reinhard J, Basset C, Holton J, Binks M, Youinou P, Vaira D. Image analysis method to assess adhesion of Helicobacter pylori to gastric epithelium using confocal laser scanning microscopy. Journal of Microbiological Methods 2000;39:179-87. [DOI: 10.1016/s0167-7012(99)00118-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
245 Suzuki H, Mori M, Seto K, Nagahashi S, Kawaguchi C, Kai A, Akiba Y, Suzuki M, Suematsu M, Miura S. Ethanol intake preceding Helicobacter pylori inoculation promotes gastric mucosal inflammation in Mongolian gerbils. J Gastroenterol Hepatol. 1999;14:1062-1069. [PMID: 10574132 DOI: 10.1046/j.1440-1746.1999.01999.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
246 Ofman JJ, Etchason J, Alexander W, Stevens BR, Herrin J, Cangialose C, Ballard DJ, Bratzler D, Elward KS, FitzGerald D, Culpepper-Morgan J, Marshall B. The quality of care for Medicare patients with peptic ulcer disease. Am J Gastroenterol 2000;95:106-13. [PMID: 10638567 DOI: 10.1111/j.1572-0241.2000.01514.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
247 Slater E, Owen RJ, Williams M, Pounder RE. Conservation of the cag pathogenicity island of Helicobacter pylori: associations with vacuolating cytotoxin allele and IS605 diversity. Gastroenterology. 1999;117:1308-1315. [PMID: 10579972 DOI: 10.1016/S0016-5085(99)70281-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.5] [Reference Citation Analysis]
248 Lee CK, Soike K, Giannasca P, Hill J, Weltzin R, Kleanthous H, Blanchard J, Monath TP. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine. 1999;17:3072-3082. [PMID: 10462242 DOI: 10.1016/s0264-410x(99)00144-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
249 Franco L, Talamini G, Carra G, Doria D. Expression of COX-1, COX-2, and inducible nitric oxide synthase protein in human gastric antrum with Helicobacter pylori infection. Prostaglandins Other Lipid Mediat. 1999;58:9-17. [PMID: 10482283 DOI: 10.1016/s0090-6980(99)00020-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
250 Ikezawa K, Kashimura H, Kojima M, Aikawa T, Nakahara A, Mutoh H, Tanaka N. Pretreatment Antimicrobial Susceptibilities of Paired Gastric Helicobacter pylori Isolates: Antrum Versus Corpus. Helicobacter 1999;4:218-21. [DOI: 10.1046/j.1523-5378.1999.99051.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
251 Mysore JV, Wigginton T, Simon PM, Zopf D, Heman-ackah LM, Dubois A. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenterology 1999;117:1316-25. [DOI: 10.1016/s0016-5085(99)70282-9] [Cited by in Crossref: 116] [Cited by in F6Publishing: 94] [Article Influence: 5.0] [Reference Citation Analysis]
252 Yoshida Y, Matsuda K, Sasaki H, Matsumoto Y, Matsumoto S, Takasugi H. Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative. Bioorganic & Medicinal Chemistry Letters 1999;9:3123-6. [DOI: 10.1016/s0960-894x(99)00549-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
253 Yoshida Y, Barrett D, Azami H, Morinaga C, Matsumoto S, Matsumoto Y, Takasugi H. Studies on Anti-Helicobacter pylori Agents. Part 1: Benzyloxyisoquinoline Derivatives. Bioorganic & Medicinal Chemistry 1999;7:2647-66. [DOI: 10.1016/s0968-0896(99)00203-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
254 Kang JY, Ho KY, Yeoh KG, Guan R, Wee A, Lee E, Lye WC, Leong SO, Tan CC. Peptic ulcer and gastritis in uraemia, with particular reference to the effect of Helicobacter pylori infection. J Gastroenterol Hepatol 1999;14:771-8. [PMID: 10482427 DOI: 10.1046/j.1440-1746.1999.01947.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
255 Fabrizi F, Martin P, Dixit V, Quan S, Brezina M, Abbey H, Gerosa S, Kaufman E, DiNello R, Polito A, Gitnick G. Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBA H. pylori SIA. Nephrol Dial Transplant 1999;14:1929-33. [PMID: 10462273 DOI: 10.1093/ndt/14.8.1929] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
256 Alarcon T, Domingo D, Lopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents. 1999;12:19-26. [PMID: 10389643 DOI: 10.1016/s0924-8579(99)00051-5] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 3.6] [Reference Citation Analysis]
257 Uygun A, Ates Y, Erdil A, Kadayifci A, Cetin C, Gulsen M, Karaeren N, Dagalp K. Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population. Clinical Therapeutics 1999;21:1539-48. [DOI: 10.1016/s0149-2918(00)80009-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
258 Elitsur Y, Adkins L, Saeed D, Neace C. Helicobacter pylori Antibody Profile in Household Members of Children with H. pylori Infection: . Journal of Clinical Gastroenterology 1999;29:178-82. [DOI: 10.1097/00004836-199909000-00015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
259 Chen M, Andersen LP, Zhai L, Kharazmi A. Characterization of the respiratory chain of Helicobacter pylori. FEMS Immunol Med Microbiol 1999;24:169-74. [PMID: 10378416 DOI: 10.1111/j.1574-695X.1999.tb01278.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
260 Ohsaki A, Takashima J, Chiba N, Kawamura M. Microanalysis of a selective potent anti-Helicobacter pylori compound in a Brazilian medicinal plant, Myroxylon peruiferum and the activity of analogues. Bioorg Med Chem Lett. 1999;9:1109-1112. [PMID: 10328294 DOI: 10.1016/s0960-894x(99)00141-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 1.6] [Reference Citation Analysis]
261 Schwartz HI, Perschy TB, McSorley DJ, Sorrells SC. Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori. Helicobacter 1999;4:121-7. [PMID: 10382126 DOI: 10.1046/j.1523-5378.1999.98005.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
262 Gómez-Duarte OG, Bumann D, Meyer TF. The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases. Vaccine. 1999;17:1667-1673. [PMID: 10194821 DOI: 10.1016/s0264-410x(98)00436-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
263 Zanten SJ, Bradette M, Farley A, Leddin D, Lind T, Unge P, Bayerdörffer E, Spiller RC, O’Morain C, Sipponen P. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther. 1999;13:289-295. [PMID: 10102960 DOI: 10.1046/j.1365-2036.1999.00471.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 4.1] [Reference Citation Analysis]
264 Cook KF, Rabeneck L, Campbell CJ, Wray NP. Evaluation of a Multidimensional Measure of Dyspepsia-Related Health for Use in a Randomized Clinical Trial. Journal of Clinical Epidemiology 1999;52:381-92. [DOI: 10.1016/s0895-4356(99)00018-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
265 Ofman JJ, Rabeneck L. The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review. Am J Med 1999;106:335-46. [PMID: 10190384 DOI: 10.1016/s0002-9343(99)00016-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
266 Mcnamara D, Whelan H, Hamilton H, Beattie S, O’morain C. HpSA: Assessment of a new non-invasive diagnostic assay for helicobacter pylori infection in an Irish population. Ir J Med Sci 1999;168:111-3. [DOI: 10.1007/bf02946478] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
267 Delvin EE, Brazier JL, Deslandres C, Alvarez F, Russo P, Seidman E. Accuracy of the [13C]-urea breath test in diagnosing Helicobacter pylori gastritis in pediatric patients. J Pediatr Gastroenterol Nutr. 1999;28:59-62. [PMID: 9890470 DOI: 10.1097/00005176-199901000-00014] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 1.9] [Reference Citation Analysis]
268 Sawada Y, Sashio H, Yamamoto N, Hida N, Akashi H, Tonokatsu Y, Sakagami T, Fukuda Y, Shimoyama T, Nishigami T. Pathologic changes in the glandular stomach and duodenum in an H. pylori-infected Mongolian gerbil model. J Clin Gastroenterol. 1998;27 Suppl 1:S141-S143. [PMID: 9872511 DOI: 10.1097/00004836-199800001-00022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
269 Tomtitchong P, Onda M, Matsukura N, Tokunaga A, Kato S, Matsuhisa T, Yamada N, Hayashi A. Helicobacter pylori infection in the remnant stomach after gastrectomy: with special reference to the difference between Billroth I and II anastomoses. J Clin Gastroenterol. 1998;27 Suppl 1:S154-S158. [PMID: 9872514 DOI: 10.1097/00004836-199800001-00025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
270 Suzuki H, Mori M, Seto K, Kai A, Kawaguchi C, Suzuki M, Suematsu M, Yoneta T, Miura S, Ishii H. Helicobacter pylori-associated gastric pro- and antioxidant formation in Mongolian gerbils. Free Radical Biology and Medicine 1999;26:679-84. [DOI: 10.1016/s0891-5849(98)00248-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 1.9] [Reference Citation Analysis]
271 Kameshima H, Yagihashi A, Yajima T, Watanabe N, Ikeda Y. Helicobacter pylori infection induces telomerase activity in premalignant lesions. Am J Gastroenterol. 1999;94:547-548. [PMID: 10022677 DOI: 10.1111/j.1572-0241.1999.00547.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
272 Miwa H, Murai T, Ohkura R, Nagahara A, Watanabe H, Terai T, Watanabe S, Sato N. Usefulness of the [13C]-urea breath test for detection of Helicobacter pylori infection in fasting patients. J Gastroenterol Hepatol. 1998;13:1039-1043. [PMID: 9835321 DOI: 10.1111/j.1440-1746.1998.tb00567.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
273 Dubois A, Berg DE, Incecik ET, Fiala N, Heman-Ackah LM, Del Valle J, Yang M, Wirth HP, Perez-Perez GI, Blaser MJ. Host specificity of Helicobacter pylori strains and host responses in experimentally challenged nonhuman primates. Gastroenterology. 1999;116:90-96. [PMID: 9869606 DOI: 10.1016/s0016-5085(99)70232-5] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 3.7] [Reference Citation Analysis]
274 Kawase M, Harada H, Saito S, Cui J, Tani S. In vitro susceptibility of Helicobacter pylori to trifluoromethyl ketones. Bioorganic & Medicinal Chemistry Letters 1999;9:193-4. [DOI: 10.1016/s0960-894x(98)00726-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
275 Peura D. Helicobacter pylori: rational management options. The American Journal of Medicine 1998;105:424-30. [DOI: 10.1016/s0002-9343(98)00297-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
276 Barkin J. The relation between Helicobacter pylori and nonsteroidal anti-inflammatory drugs. Am J Med. 1998;105:22S-27S. [PMID: 9855172 DOI: 10.1016/S0002-9343(98)00277-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
277 Bazzoli F, Pozzato P, Zagari M, Fossi S, Ricciardiello L, Nicolini G, Berretti D, De Luca L. Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis. Helicobacter. 1998;3:195-201. [PMID: 9731991 DOI: 10.1046/j.1523-5378.1998.08029.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
278 Kitamoto N, Nakamoto H, Katai A, Takahara N, Nakata H, Tamaki H, Tanaka T. Heterogeneity of protein profiles of Helicobacter pylori isolated from individual patients. Helicobacter 1998;3:152-62. [PMID: 9731984 DOI: 10.1046/j.1523-5378.1998.08703.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
279 Braden B, Wenke A, Karich HJ, Dietrich CF, Scharrer I, Caspary WF, Lembcke B. Risk of gastrointestinal bleeding associated with Helicobacter pylori infection in patients with hemophilia or von Willebrand’s syndrome. Helicobacter. 1998;3:184-187. [PMID: 9731989 DOI: 10.1046/j.1523-5378.1998.08052.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
280 Hunt RH, Lam SK. Helicobacter pylori: from art to a science. J Gastroenterol Hepatol 1998;13:21-8. [PMID: 9737567 DOI: 10.1111/j.1440-1746.1998.tb00540.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
281 Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol. 1998;13:1-12. [PMID: 9737564 DOI: 10.1111/j.1440-1746.1998.tb00537.x] [Cited by in Crossref: 298] [Cited by in F6Publishing: 290] [Article Influence: 12.4] [Reference Citation Analysis]
282 Tanahashi T, Kodama T, Yamaoka Y, Sawai N, Tatsumi Y, Kashima K, Higashi Y, Sasaki Y. Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy. J Gastroenterol Hepatol. 1998;13:732-737. [PMID: 9715426 DOI: 10.1111/j.1440-1746.1998.tb00722.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
283 Kim SY, Ahn JS, Ha YJ, Doh HJ, Jang MH, Chung SI, Park HJ. Serodiagnosis of Helicobacter pylori Infection in Korean Patients Using Enzyme-Linked Immunosorbent Assay. Journal of Immunoassay 1998;19:251-70. [DOI: 10.1080/01971529808005485] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
284 Forbes GM, Threlfall TJ. Treatment of Helicobacter pylori infection to reduce gastric cancer incidence: Uncertain benefits of a community based programme in Australia. J Gastroenterol Hepatol 1998;13:1091-5. [DOI: 10.1111/j.1440-1746.1998.tb00581.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
285 Kato S, Abukawa D, Furuyama N, Iinuma K. Helicobacter pylori Reinfection Rates in Children After Eradication Therapy: . Journal of Pediatric Gastroenterology & Nutrition 1998;27:543-6. [DOI: 10.1097/00005176-199811000-00009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
286 Mcghee JR, Bliss CM, Golenbock DT, Keates S, Linevsky JK, Kelly CP. Helicobacter pylori Lipopolysaccharide Binds to CD14 and Stimulates Release of Interleukin-8, Epithelial Neutrophil-Activating Peptide 78, and Monocyte Chemotactic Protein 1 by Human Monocytes. Infect Immun 1998;66:5357-63. [DOI: 10.1128/iai.66.11.5357-5363.1998] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 2.7] [Reference Citation Analysis]
287 Ahuja V, Dhar A, Bal C, Sharma MP. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. Aliment Pharmacol Ther 1998;12:551-5. [PMID: 9678815 DOI: 10.1046/j.1365-2036.1998.00338.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
288 Lieber CS. Gastritis in the alcoholic: relationship to gastric alcohol metabolism and Helicobacter pylori. Addict Biol 1998;3:423-33. [PMID: 26735117 DOI: 10.1080/13556219871967] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
289 Wang TC, Fox JG. Helicobacter pylori and gastric cancer: Koch's postulates fulfilled. Gastroenterology. 1998;115:780-783. [PMID: 9742001 DOI: 10.1016/s0016-5085(98)70159-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
290 Gomollón F, Ducóns JA, Gimeno L, Fuentes J, García S, Vera J, Montoro M. The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain. Helicobacter. 1998;3:110-114. [PMID: 9631309 DOI: 10.1046/j.1523-5378.1998.08039.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
291 Miwa H, Ohkura R, Murai T, Nagahara A, Yamada T, Ogihara T, Watanabe S, Sato N. Effectiveness of omeprazole-amoxicillin-clarithromycin (OAC) therapy for Helicobacter pylori infection in a Japanese population. Helicobacter. 1998;3:132-138. [PMID: 9631313 DOI: 10.1046/j.1523-5378.1998.08041.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
292 Furuta T, Takashima M, Futami H, Arai H, Hanai H, Kaneko E. Amount of Helicobacter pylori in gastric mucus during anti-H. pylori treatment. J Gastroenterol Hepatol 1998;13:511-5. [PMID: 9641650 DOI: 10.1111/j.1440-1746.1998.tb00678.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
293 Logan RP, Robins A, Turner GA, Cockayne A, Borriello SP, Hawkey CJ. A novel flow cytometric assay for quantitating adherence of Helicobacter pylori to gastric epithelial cells. J Immunol Methods 1998;213:19-30. [PMID: 9671122 DOI: 10.1016/s0022-1759(98)00018-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 1.8] [Reference Citation Analysis]
294 de Boer WA, Haeck PW, Otten MH, Mulder CJ. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. Am J Gastroenterol. 1998;93:1101-1107. [PMID: 9672338 DOI: 10.1111/j.1572-0241.1998.00337.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
295 Rabeneck L, Wray NP, Graham DY. Managing dyspepsia: what do we know and what do we need to know? Am J Gastroenterol 1998;93:920-4. [PMID: 9647019 DOI: 10.1111/j.1572-0241.1998.277_e.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
296 Schoenfeld P, Cook D, Hamilton F, Laine L, Morgan D, Peterson W. An evidence-based approach to gastroenterology therapy. Evidence-Based Gastroenterology Steering Group. Gastroenterology 1998;114:1318-25. [PMID: 9609770 DOI: 10.1016/s0016-5085(98)70439-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 1.8] [Reference Citation Analysis]
297 Nawaz A, Mohammed I, Ahsan K, Karakurum A, Hadjiyane C, Pellecchia C. CLOSTRIDIUM DIFFICILE COLITIS ASSOCIATED WITH TREATMENT OF HELICOBACTER PYLORI INFECTION. American Journal of Gastroenterology 1998;93:1175-6. [DOI: 10.1111/j.1572-0241.1998.00358.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
298 Cutler AF, Prasad VM, Santogade P. Four-year trends in Helicobacter pylori IgG serology following successful eradication. The American Journal of Medicine 1998;105:18-20. [DOI: 10.1016/s0002-9343(98)00134-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
299 Levin TR, Schmittdiel JA, Henning JM, Kunz K, Henke CJ, Colby CJ, Selby JV. A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization. Am J Gastroenterol. 1998;93:743-747. [PMID: 9625120 DOI: 10.1111/j.1572-0241.1998.217_a.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
300 Andersen RN, Ganeshkumar N, Kolenbrander PE. Helicobacter pylori adheres selectively to Fusobacterium spp. Oral Microbiol Immunol. 1998;13:51-54. [PMID: 9573823 DOI: 10.1111/j.1399-302x.1998.tb00751.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.4] [Reference Citation Analysis]
301 Suzuki H, Suzuki M, Mori M, Kitahora T, Yokoyama H, Miura S, Hibi T, Ishii H. Augmented levels of gastric mucosal leucocyte activation by infection with cagA gene-positive Helicobacter pylori. J Gastroenterol Hepatol 1998;13:294-300. [PMID: 9570243 DOI: 10.1111/j.1440-1746.1998.01558.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
302 Fraser AG, Schreuder V, Chua L, Moore L. Follow up after successful eradication of Helicobacter pylori: Symptoms and reinfection. J Gastroenterol Hepatol 1998;13:555-9. [DOI: 10.1111/j.1440-1746.1998.tb00689.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
303 Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol. 1998;93:574-578. [PMID: 9576450 DOI: 10.1111/j.1572-0241.1998.167_b.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 4.2] [Reference Citation Analysis]
304 Henihan RD, Stuart RC, Nolan N, Gorey TF, Hennessy TP, O'Morain CA. Barrett's esophagus and the presence of Helicobacter pylori. Am J Gastroenterol. 1998;93:542-546. [PMID: 9576445 DOI: 10.1111/j.1572-0241.1998.162_b.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
305 Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Am J Gastroenterol. 1998;93:584-590. [PMID: 9576452 DOI: 10.1111/j.1572-0241.1998.169_b.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 1.9] [Reference Citation Analysis]
306 Iwaki H, Sugiyama T, Asaka M. A modified McMullen's staining for Helicobacter pylori: a high-contrast, visibly prominent method. Helicobacter 1998;3:45-8. [PMID: 9546117 DOI: 10.1046/j.1523-5378.1998.08013.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
307 Treiber G, Ammon S, Schneider E, Klotz U. Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication. Helicobacter. 1998;3:54-58. [PMID: 9546119 DOI: 10.1046/j.1523-5378.1998.08019.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 3.1] [Reference Citation Analysis]
308 Thamer &, Ray NF, Henderson SC, Rinehart CS, Sherman CR, Ferguson JH. Influence of the NIH Consensus Conference on Helicobacter Pylori on Physician Prescribing Among a Medicaid Population: . Medical Care 1998;36:646-60. [DOI: 10.1097/00005650-199805000-00005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
309 Suzuki H, Mori M, Sakaguchi AA, Suzuki M, Miura S, Ishii H. Enhanced levels of C-X-C chemokine, human GROα, in Helicobacter pylori-associated gastric disease. J Gastroenterol Hepatol 1998;13:516-20. [DOI: 10.1111/j.1440-1746.1998.tb00679.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
310 Parsonnet J. Helicobacter pylori. Infect Dis Clin North Am. 1998;12:185-197. [PMID: 9494838 DOI: 10.1016/s0891-5520(05)70417-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 2.8] [Reference Citation Analysis]
311 Disi AM, Tamimi SO, Abuereish GM. Effects of Anchusa strigosa root aqueous extract on gastric ethanol-induced ulcer in laboratory animals. Journal of Ethnopharmacology 1998;60:189-98. [DOI: 10.1016/s0378-8741(97)00134-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
312 Sprung DJ, Apter MN. What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities? J Clin Gastroenterol. 1998;26:60-63. [PMID: 9492867 DOI: 10.1097/00004836-199801000-00016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
313 Yeomans ND, Tulassay Z, Juhász L, Rácz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998;338:719-26. [PMID: 9494148 DOI: 10.1056/NEJM199803123381104] [Cited by in Crossref: 543] [Cited by in F6Publishing: 459] [Article Influence: 22.6] [Reference Citation Analysis]
314 Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, Clerici E, de Franchis R. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas.J Clin Gastroenterol. 1997;25:605-607. [PMID: 9451672 DOI: 10.1097/00004836-199712000-00011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 62] [Article Influence: 2.2] [Reference Citation Analysis]
315 Kuykendall DH, Rabeneck L, Campbell CJ, Wray NP. Dyspepsia: how should we measure it? J Clin Epidemiol 1998;51:99-106. [PMID: 9474070 DOI: 10.1016/s0895-4356(97)00245-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 36] [Article Influence: 1.1] [Reference Citation Analysis]
316 van der Hulst RW, Keller JJ, Rauws EA, Tytgat GN. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter. 1996;1:6-19. [PMID: 9398908 DOI: 10.1111/j.1523-5378.1996.tb00003.x] [Cited by in Crossref: 203] [Cited by in F6Publishing: 206] [Article Influence: 8.5] [Reference Citation Analysis]
317 O'Morain C, Dettmer A, Rambow A, von Fritsch E, Fraser AG. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. Helicobacter. 1996;1:130-137. [PMID: 9398893 DOI: 10.1111/j.1523-5378.1996.tb00026.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
318 Yousfi MM, Reddy R, Osato MS, Graham DY. Is antrum or corpus the best site for culture of Helicobacter pylori? Helicobacter. 1996;1:88-91. [PMID: 9398884 DOI: 10.1111/j.1523-5378.1996.tb00016.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
319 Moayyedi P, Langworthy H, Shanahan K, Tompkins DS, Dixon MF, Chalmers DM, Axon AT. Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori. Helicobacter 1996;1:71-4. [PMID: 9398880 DOI: 10.1111/j.1523-5378.1996.tb00012.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
320 Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdörffer E, O'Morain C, Bardhan KD, Bradette M, Chiba N, Wrangstadh M. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter. 1996;1:138-144. [PMID: 9398894 DOI: 10.1111/j.1523-5378.1996.tb00027.x] [Cited by in Crossref: 391] [Cited by in F6Publishing: 391] [Article Influence: 16.3] [Reference Citation Analysis]
321 Ling TK, Cheng AF, Sung JJ, Yiu PY, Chung SS. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter. 1996;1:57-61. [PMID: 9398914 DOI: 10.1111/j.1523-5378.1996.tb00009.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 3.1] [Reference Citation Analysis]
322 Miwa H, Ohkura R, Nagahara A, Murai T, Ogihara T, Watanabe S, Hirai S, Sato N. [13C]-Urea Breath Test for Assessment of Cure of Helicobacter pylori Infection at 1 month After Treatment: . Journal of Clinical Gastroenterology 1998;27:S150-3. [DOI: 10.1097/00004836-199800001-00024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
323 Dattilo M, Figura N. Helicobacter pylori Infection, Chronic Gastritis, and Proton Pump Inhibitors: . Journal of Clinical Gastroenterology 1998;27:S163-9. [DOI: 10.1097/00004836-199800001-00027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
324 Vaira D, Menegatti M, Miglioli M. What is the role of Helicobacter pylori in complicated ulcer disease? Gastroenterology. 1997;113:S78-S84. [PMID: 9394765 DOI: 10.1016/s0016-5085(97)80017-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
325 Howden CW. For what conditions is there evidence-based justification for treatment of Helicobacter pylori infection? Gastroenterology 1997;113:S107-12. [PMID: 9394770 DOI: 10.1016/s0016-5085(97)80022-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
326 Begue RE, Gonzales JL, Correa-Gracian H, Tang SC. Helicobacter pylori infection in children with abdominal ailments in a developing country. Am J Med Sci. 1997;314:279-283. [PMID: 9365327 DOI: 10.1097/00000441-199711000-00001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
327 Matsumoto S, Washizuka Y, Matsumoto Y, Tawara S, Ikeda F, Yokota Y, Karita M. Appearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains. Antimicrob Agents Chemother 1997;41:2602-5. [DOI: 10.1128/aac.41.12.2602] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
328 Rall CJ, Munshi AD, Stasior DS. DISEASE MANAGEMENT STRATEGIES AND THE GASTROENTEROLOGIST. Gastroenterology Clinics of North America 1997;26:873-94. [DOI: 10.1016/s0889-8553(05)70339-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
329 Kehrt R, Becker M, Brösicke H, Krüger N, Helge H. Prevalence of Helicobacter pylori infection in Nicaraguan children with persistent diarrhea, diagnosed by the 13C-urea breath test. J Pediatr Gastroenterol Nutr 1997;25:84-8. [PMID: 9226533 DOI: 10.1097/00005176-199707000-00014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 1.3] [Reference Citation Analysis]
330 Treiber G, Ammon S, Klotz U. Age-dependent eradication of Helicobacter pylori with dual therapy. Aliment Pharmacol Ther 1997;11:711-8. [PMID: 9305480 DOI: 10.1046/j.1365-2036.1997.00210.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
331 Lieber CS. Gastric Ethanol Metabolism and Gastritis: Interactions with Other Drugs, Helicobacter pylori, and Antibiotic Therapy (1957-1997)-a Review. Alcoholism Clin Exp Res 1997;21:1360-6. [DOI: 10.1111/j.1530-0277.1997.tb04463.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
332 Huang JQ, Hunt RH. Review: eradication of Helicobacter pylori. Problems and recommendations. J Gastroenterol Hepatol. 1997;12:590-598. [PMID: 9304512 DOI: 10.1111/j.1440-1746.1997.tb00491.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
333 Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-41. [DOI: 10.1128/cmr.10.4.720] [Cited by in Crossref: 902] [Cited by in F6Publishing: 888] [Article Influence: 36.1] [Reference Citation Analysis]
334 Kadota S, Basnet P, Ishii E, Tamura T, Namba T. Antibacterial activity of trichorabdal A from Rabdosia trichocarpa against Helicobacter pylori. Zentralbl Bakteriol. 1997;286:63-67. [PMID: 9241802 DOI: 10.1016/s0934-8840(97)80076-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
335 Levenstein S, Kaplan GA, Smith MW. Psychological predictors of peptic ulcer incidence in the Alameda County Study. J Clin Gastroenterol 1997;24:140-6. [PMID: 9179731 DOI: 10.1097/00004836-199704000-00004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
336 Segura AM, Gutiérrez O, Otero W, Angel A, Genta RM, Graham DY. Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1997;11:529-532. [PMID: 9218077 DOI: 10.1046/j.1365-2036.1997.00172.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
337 Scheiman JM. NSAIDs, gastrointestinal injury, and cytoprotection. Gastroenterol Clin North Am. 1996;25:279-298. [PMID: 9229573 DOI: 10.1016/s0889-8553(05)70247-8] [Cited by in Crossref: 96] [Cited by in F6Publishing: 91] [Article Influence: 3.8] [Reference Citation Analysis]
338 Williams MP, Hamilton MR, Sercombe JC, Pounder RE. Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride. Aliment Pharmacol Ther 1997;11:705-10. [DOI: 10.1046/j.1365-2036.1997.00224.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
339 Sathar M, Gouws E, Simjee A, Mayat A. Seroepidemiological study of Helicobacter pylori infection in South African children. Transactions of the Royal Society of Tropical Medicine and Hygiene 1997;91:393-5. [DOI: 10.1016/s0035-9203(97)90253-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
340 Makovec F, D'amato M. CCKB/gastrin receptor antagonists as potential drugs for peptic ulcer therapy. Drug Discovery Today 1997;2:283-93. [DOI: 10.1016/s1359-6446(97)01044-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
341 Labenz J, Beker J, Dekkers C, Farley A, Klor H, Jonsson A. Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients. Aliment Pharmacol Ther 1997;11:515-22. [DOI: 10.1046/j.1365-2036.1997.00169.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
342 Breuer T, Kim JG, Gurer IE, Graham DP, Osato M, Genta RM, Graham DY. Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther 1997;11:523-7. [DOI: 10.1046/j.1365-2036.1997.00173.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
343 Forbes GM. Review: Helicobacter pylori. Current issues and new directions. J Gastroenterol Hepatol 1997;12:419-24. [DOI: 10.1111/j.1440-1746.1997.tb00459.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
344 Mathé G. Is the study of human cancer-associated factors, the best or the only model for human carcinogenesis research? I. The question of Helicobacter pylori infection as an accused human gastric carcinogen. Biomed Pharmacother 1997;51:1-4. [PMID: 9084723 DOI: 10.1016/S0753-3322(97)87072-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
345 Bonamico M, Mariani P, Magliocca FM, Petrozza V, Montuori M, Pezzella C, Luzzi I, Carpino F. Helicobacter pylori duodenal colonization in children. Acta Paediatr 1997;86:356-60. [PMID: 9174219 DOI: 10.1111/j.1651-2227.1997.tb09022.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
346 Chen XQ, Zhang WD, Jiang B, Song YG, Reng RZ, Zhou DY. Reduced secretion of epidermal growth factor in duodenal ulcer patients with Helicobacter pylori infection. World J Gastroenterol 1997; 3(1): 31-34 [PMID: 27006581 DOI: 10.3748/wjg.v3.i1.31] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
347 Yousfi MM, el-Zimaity HM, Genta RM, Graham DY. Evaluation of a new reagent strip rapid urease test for detection of Helicobacter pylori infection. Gastrointest Endosc. 1996;44:519-522. [PMID: 8934154 DOI: 10.1016/s0016-5107(96)70001-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
348 Yousfi MM, El-Zimaity HM, Cole RA, Genta RM, Graham DY. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). Aliment Pharmacol Ther. 1996;10:119-122. [PMID: 8871452 DOI: 10.1111/j.1365-2036.1996.tb00185.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
349 Fletcher DR. PEPTIC DISEASE: CAN WE AFFORD CURRENT MANAGEMENT? ANZ J Surg 1997;67:75-80. [DOI: 10.1111/j.1445-2197.1997.tb01908.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
350 Hirth RA, Fendrick AM, Chernew ME. Specialist and generalist physicians' adoption of antibiotic therapy to eradicate Helicobacter pylori infection. Med Care 1996;34:1199-204. [PMID: 8962586 DOI: 10.1097/00005650-199612000-00005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
351 Shibata T, Imoto I, Gabazza E. Detection of helicobacter pylori in biopsy of patients with gastric carcinoma. Biomedicine & Pharmacotherapy 1997;51:22-8. [DOI: 10.1016/s0753-3322(97)87075-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
352 Salaspuro M. Microbial metabolism of ethanol and acetaldehyde and clinical consequences. Addict Biol 1997;2:35-46. [PMID: 26735439 DOI: 10.1080/13556219772840] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
353 Matsukura N, Onda M, Tokunaga A, Kato S, Yoshiyuki T, Hasegawa H, Yamashita K, Tomtitchong P, Hayashi A. Role of Helicobacter pylori Infection in Perforation of Peptic Ulcer: An Age- and Gender-Matched Case-Control Study: . Journal of Clinical Gastroenterology 1997;25:S235-9. [DOI: 10.1097/00004836-199700001-00037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
354 Yousfi MM, el-Zimaity HM, Cole RA, Genta RM, Graham DY. Resolution of a metaplastic duodenal polyp after cure of Helicobacter pylori infection. J Clin Gastroenterol 1996;23:53-4. [PMID: 8835902 DOI: 10.1097/00004836-199607000-00015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
355 Riff DS, Kidd S, Rose P, Haber M, Weissfeld A, Siepman N. Triple Therapy with Lansoprazole, Clarithromycin, and Amoxicillin for the Cure of Helicobacter pylori Infection: A Short Report. Helicobacter 1996;1:238-42. [DOI: 10.1111/j.1523-5378.1996.tb00045.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
356 Harford W, Lanza F, Arora A, Graham D, Haber M, Weissfeld A, Rose P, Siepman N. Double-Blind, Multicenter Evaluation of Lansoprazole and Amoxicillin Dual Therapy for the Cure of Helicobacter pylori Infection. Helicobacter 1996;1:243-50. [DOI: 10.1111/j.1523-5378.1996.tb00046.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
357 Hardikar W, Grimwood K. Prevalence of Helicobacter pylori infection in asymptomatic children. J Paediatr Child Health. 1995;31:537-541. [PMID: 8924307 DOI: 10.1111/j.1440-1754.1995.tb00879.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
358 Alhomsi MF, Adeyemi EO. Grading Helicobacter pylori gastritis in dyspeptic patients. Comp Immunol Microbiol Infect Dis. 1996;19:147-154. [PMID: 8814977 DOI: 10.1016/0147-9571(95)00028-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
359 Scheiman JM, Chey WD, Behler EM, Crause I, Elta GH. One-Week Therapy for Helicobacter pylori: A Randomized Trial of Two Treatment Regimens. Journal of Clinical Gastroenterology 1996;23:170-3. [DOI: 10.1097/00004836-199610000-00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
360 Bourke B, Jones N, Sherman P. Helicobacter pylori infection and peptic ulcer disease in children. Pediatr Infect Dis J. 1996;15:1-13. [PMID: 8684868 DOI: 10.1097/00006454-199601000-00002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
361 de Boer WA. How to Achieve a Near 100% Cure Rate for H. Pylori Infection in Peptic Ulcer Patients: A Personal Viewpoint. Journal of Clinical Gastroenterology 1996;22:313-6. [DOI: 10.1097/00004836-199606000-00016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 1.5] [Reference Citation Analysis]
362 Götz J, Ravensbergen J, Verspaget H, Biemond I, Sier C, Offerhaus G, Lamers C, Veenendaal R. The effect of treatment of Helicobacter pylori infection on gastric mucosal plasminogen activators. Fibrinolysis 1996;10:85-9. [DOI: 10.1016/s0268-9499(96)80057-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
363 Götz JM, van Kan CI, Verspaget HW, Biemond I, Lamers CB, Veenendaal RA. Gastric mucosal superoxide dismutases in Helicobacter pylori infection. Gut 1996;38:502-6. [PMID: 8707077 DOI: 10.1136/gut.38.4.502] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
364 Yousfi MM, Reddy R, Osato MS, Graham DY. Culture of Helicobacter pylori: Effect of Preimmersion of Biopsy Forceps in Formalin. Helicobacter 1996;1:62-4. [DOI: 10.1111/j.1523-5378.1996.tb00010.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
365 Yousfi MM, El-zimaity HM, Cole RA, Genta RM, Graham DY. Detection of Helicobacter pylori by rapid urease tests: is biopsy size a critical variable? Gastrointestinal Endoscopy 1996;43:222-4. [DOI: 10.1016/s0016-5107(96)70320-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.2] [Reference Citation Analysis]
366 Yousfi MM, el-Zimaity HM, al-Assi MT, Cole RA, Genta RM, Graham DY. Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:209-12. [PMID: 7605865 DOI: 10.1111/j.1365-2036.1995.tb00374.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 1.9] [Reference Citation Analysis]